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ABSTRACT 
Classical conditioning of the eyeblink response is a form of motor learning that is 
controlled by the intermediate cerebellum and related brainstem structures.  A major 
component of this neural network is the inferior olive (IO), which is the exclusive source of 
cerebellar climbing fibers.  The functional role of the IO in eyeblink conditioning circuits is 
not completely understood.  Pertinent to eyeblink conditioning, there are two competing 
concepts explaining IO function.  The cerebellar learning hypothesis assumes that, by 
conveying the unconditioned stimulus (US) input, the IO is supplying the cerebellum with a 
“teaching” signal required for the acquisition of conditioned responses (CR).  This 
hypothesis predicts that blocking US input should lead to the extinction of CRs.  An alternate 
concept assumes that the IO regulates the tonic activity of the neural network, and predicts 
that inactivation of the IO would produce dysfunction of the cerebellum.  To examine these 
hypotheses, we designed a series of studies probing the behavioral and electrophysiological 
effects of blocking US sensory input to the IO.  The unique feature of these experiments is 
that they are the first to document effects of IO manipulations on the neuronal activity in the 
cerebellum. 
In the first series of experiments, we found that blocking glutamatergic sensory inputs 
to the IO or inactivating the IO gradually abolished CRs.  In additional tests we determined 
that the gradual disappearance of CRs was related to drug diffusion rather than to CR 
extinction.  Since these behavioral effects were paralleled by a dramatic suppression of 
interposed nucleus (IN) neuronal activity, we concluded that inactivating the rostral parts of 
the IO complex abolishes CRs by producing a tonic dysfunction of cerebellar eyeblink 
conditioning circuits.  
  
 
vii
In the second series of experiments, we tested a recent suggestion that selectively 
blocking AMPA/kainate receptors in the IO blocks the teaching signal to the cerebellum 
without affecting the tonic state of the cerebellum.  In this pivotal experiment, we found that 
blocking AMPA/kainate receptors in the IO abolishes CRs by suppressing both the tonic and 
CR-related neuronal activity in the IN and that the delayed (extinction-like) behavioral 
effects of NBQX most likely stem from the gradual diffusion of injected drug. 
The first two experiments significantly weakened the cerebellar learning hypothesis 
because they demonstrated that the physiological mechanisms explaining the behavioral 
effects of common IO manipulations is inconsistent with this notion.  We proposed that the 
ultimate test of the cerebellar learning hypothesis would be blocking IO sensory inputs 
without upsetting the tonic activity in the cerebellum.  To achieve this goal, we initiated a 
third group of studies to develop a new pharmacological approach that would counter-
balance the tonic effects of glutamate blockers.  We examined two drug candidates, 
harmaline and gabazine, for their potential to elevate IO spontaneous activity.  In these 
preliminary studies, we found that the GABA-A antagonist gabazine could recover CRs and 
IN neuronal activity that had been suppressed by the prior blocking of glutamate receptors 
with DGG.  These ongoing experiments suggest that a near normal level of IO firing is 
critical for CR performance, and that US signals via the IO are most likely not required for 
the maintenance of learned responses. 
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CHAPTER 1.  GENERAL INTRODUCTION 
1.1 Dissertation Organization 
This dissertation investigates the functional role of the inferior olive in a neuronal 
circuit involved in associative learning.  It contains the experimental results obtained by the 
author during her graduate study under guidance and supervision of her major professor, Dr. 
Bracha.  It is written in an alternative thesis format, containing a general introduction, two 
research papers, a report of preliminary data for future investigations, general conclusions 
and acknowledgments. 
Chapter 1 includes a short introduction, research hypotheses, background and 
literature review of the eyeblink classical conditioning paradigm, the neuronal circuit 
associated with it, description of cerebellar learning hypothesis, inferior olive and the 
controversy about its functional role in associative learning and memory. 
Chapter 2 and Chapter 3 are arranged in a journal format representing two 
manuscripts in the form prepared for publication: 
1.  Zbarska S, Holland E, Bloedel JR, Bracha V (2007) Inferior olivary inactivation 
abolishes conditioned eyeblinks: extinction or cerebellar malfunction? Behavioral Brain 
Research, 178(1): 128-138. 
2.  Zbarska S, Bloedel JR, Bracha V (2007)  Cerebellar dysfunction explains the 
extinction-like abolition of conditioned eyeblinks following NBQX injections in the inferior 
olive. Accepted by The Journal of Neuroscience. 
Chapter 4 contains exploratory preliminary results for future investigation.  It is also 
written in a journal paper format.  The closing Chapter 5 contains general conclusions, 
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recommendations for future research and acknowledgments.  References are listed at the end 
of each chapter. 
1.2 Introduction 
Associative learning is a fundamental type of memory.  One of the best investigated 
models of associative learning is the classical conditioning of eyeblink reflexes.  The learning 
of classically conditioned eyeblinks critically depends on intermediate cerebellar neural 
circuits (Thompson, 1990; Yeo, 1991).  One of the major components of this neural network 
is the inferior olive (IO), which is the exclusive source of cerebellar climbing fibers (Desclin, 
1974).  The role of the IO in this neural circuit is not well understood.  There are two major 
hypotheses explaining the IO’s function in eyeblink conditioning.  The popular cerebellar 
learning hypothesis suggests that the IO provides the cerebellum with an error or “teaching” 
signal that is essential for learning (Marr, 1969; Thompson, 1986).  An alternate concept, 
termed the tonic hypothesis, assumes that the IO regulates the tonic activity of the system 
(Strata and Montarolo, 1982; Cerminara and Rawson, 2004).  Discriminating between these 
two hypotheses has been difficult, mostly because of uncertainties associated with IO 
lesioning/inactivation side-effects and because of methodological difficulties related to long-
term neuronal recording during neuropharmacological experiments in animals performing 
learning tasks.  As a result, even though dissociating between these hypotheses requires 
demonstrating that manipulations of the IO either do or do not alter the tonic activity of the 
cerebellum, no studies of this kind have yet been performed.  In this thesis, we proposed to 
fill this crucial gap by utilizing our unique method of long term recording of multiple single-
units in experiments involving pharmacological manipulations of the IO. 
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We designed three inter-related experiments that examined predictions of the 
cerebellar learning and tonic hypotheses both at the cellular and behavioral levels.  In the first 
experiment, we were the first to demonstrate that inactivation of the IO, either with the 
GABA agonist muscimol or with the wide spectrum glutamate antagonist DGG, abolished 
learned responses because of cerebellar dysfunction.  In the second experiment, we examined 
whether a more refined block of IO inputs with the more selective AMPA/kainate blocker 
NBQX could selectively block IO’s sensory inputs without disturbing tonic activity in the 
cerebellum.  In this critical experiment, we disproved the previously influential notion that 
the effects of NBQX on CRs are pivotal evidence for the cerebellar learning hypothesis 
(Medina et al., 2002).  We have shown that tonic effects induced by blocking AMPA/kainate 
receptors in the IO alter the functional state of involved circuits making the testing of 
cerebellar learning hypotheses impossible.  Results from the first experiment were published 
while results from the second experiment have been submitted for publication.  From this 
part of the dissertation, we concluded that the tonic hypothesis is true and that the cerebellar 
learning hypothesis is unlikely but it can not be excluded.  We found that future tests of the 
learning hypothesis will require new tools that would block sensory inputs to the IO without 
affecting its tonic activity.  In our ongoing research, we are examining possible solutions to 
this problem.  Specifically, we are assessing whether tonic effects caused by glutamate 
blockers can be offset by concurrent application of drugs that enhance IO activity.  Here we 
report highly promising preliminary results from this third experiment. 
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1.3 Research Hypotheses 
The research in this dissertation was based on three inter-related hypotheses of IO 
function.  The first two hypotheses addressed the expected mechanisms of IO inactivation, 
first at the behavioral and then at the neuronal activity levels.  The third hypothesis 
capitalizes on knowledge we acquired during the first two phases of the research and 
proposes a principally new approach to addressing IO function. 
The first hypothesis focused on the behavioral consequences of IO inactivation, 
because much of the debate about IO function centered on the timing of the conditioned 
responses (CR) loss caused by this experimental intervention.  Two studies reported that IO 
inactivation or lesioning abolishes CRs gradually over one (Medina et al., 2002) or several 
training sessions (McCormick et al., 1985).  Since gradual CR abolition resembles behavioral 
extinction, these findings were viewed as supporting the cerebellar learning hypothesis, 
which assumes that the IO provides the cerebellum with the unconditioned stimulus 
information.  Observations of gradual CR abolition were contradicted by reports indicating 
that CR suppression ensues immediately following IO lesioning (Yeo et al., 1986) or 
inactivation (Welsh and Harvey, 1998).  These findings seem to oppose the cerebellar 
learning hypothesis, as they indicate that IO inactivation induces immediate dysfunction of 
cerebellar circuits.  These contradictory studies were difficult to reconcile because most of 
them could not exclude whether observed effects were due to blocking non-olivary axons, 
and because they did not measure the effects of IO manipulations on the cerebellum.  To 
eliminate one of these deficiencies, we inactivated the IO using methods that spare fibers of 
passage.  Specifically, we inactivated the IO with injections of either the glutamate 
antagonists, DGG or NBQX, or with the GABA-A agonist muscimol.  We hypothesized: 
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Inactivation of the IO by a glutamate antagonist, or inhibition of the IO by a GABA-A 
agonist, does not lead to CR extinction, but instead produces immediate abolition of 
learned responses.  This will implicate the tonic hypothesis as best explaining IO function. 
The second hypothesis addressed neuronal mechanisms of the IO inactivation-related 
CR suppression.  The learning and tonic hypotheses make clear predictions regarding 
neurophysiological consequences of blocking IO input to the cerebellum.  The tonic 
hypothesis predicts that inactivating the IO should induce tonic dysfunction of cerebellar 
circuits.  On the other hand, the learning hypothesis predicts that blocking the IO should 
prevent the cerebellum from receiving the information about the unconditioned stimulus, 
which should result in the gradual disappearance, or extinction, of the neural correlates of 
CRs.  To examine these predictions, it was necessary to measure changes in cerebellar 
neuronal activity while pharmacologically blocking glutamatergic sensory inputs to the IO.  
This was an extremely challenging task which we solved using an innovative combination of 
intracranial microinjections and multi-channel single-unit recordings.  In these experiments, 
sensory inputs to the IO were blocked by one of the glutamate antagonists, DGG or NBQX, 
and neuronal activity in the cerebellar interposed nuclei was measured with chronically 
implanted microwire electrode arrays.  Since the results of our behavioral experiments 
supported the validity of the tonic hypothesis, we hypothesized that inactivating the IO with 
a glutamate antagonist suppresses baseline activity in the IN and that this translates into 
an immediate abolition of CRs.  Confirming this will further support the tonic hypothesis 
of IO function.   
The third hypothesis emerged directly from the outcomes of experiments that tested 
the first two hypotheses.  Results from the first and second series of experiments 
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demonstrated the validity of the tonic hypothesis of IO function.  Paradoxically, showing 
tonic regulatory effects of the IO did not disprove the learning hypothesis.  In principle it is 
possible that these hypotheses are not mutually exclusive.  The IO could regulate cerebellar 
tonic activity and at the same time it could supply the cerebellum with error signals for 
learning.  If so, then tonic effects elicited by IO inactivation would always obscure processes 
involved in learning.  Could this problem of one physiological process obscuring the other be 
dissociated experimentally?  Theoretically yes, if one successfully blocks sensory inputs in 
the IO without changing its spontaneous activity.  Since sensory inputs in the IO are 
glutamatergic, blocking these inputs will inevitably decrease IO activity.  Revealing a 
possible teaching function of the IO would then require restoring IO tonic activity by some 
other means.  Here we report exploratory experiments testing if a glutamate block-induced 
suppression of IO spontaneous activity could be restored or counter-balanced by two drug 
candidates.  The first of them was harmaline, which is an indole alkaloid known to produce 
rhythmic activation of IO neurons.  Our second choice was the GABA-A receptor antagonist, 
gabazine.  These experiments test the following hypothesis: Blocking glutamatergic sensory 
inputs in the IO while preventing major shifts in its spontaneous activity does not abolish 
CR expression.  Therefore, IO-mediated error signals are not essential for eyeblink 
conditioning. 
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1.4 Background and Literature Review 
1.4.1 Overview of eyeblink conditioning and its neural circuitry  
Eyeblink classical conditioning is a simple form of associative learning.  The 
eyeblink conditioning paradigm is a popular neurobiological model of learning and memory, 
which has benefited from a detailed knowledge of underlying neural circuits and from 
exquisite control over the involved learning variables.  It has been demonstrated that this 
form of learning critically depends on intermediate cerebellar neural circuits. 
Classical conditioning of the eyeblink reflex 
Rabbits, because of their size and docile nature, have become the preferred 
mammalian model in eyeblink conditioning studies (Gormezano, 1966; Patterson, 1976).  
Mammals, in general, exhibit an inborn eyeblink reflex (unconditioned response - UR), 
which can be elicited by aversive stimulation of the eye (Gantt, 1968).  In rabbits, eyeblinks 
consist of the coupled movements of the external eyelids and nictitating membrane.  As a 
type of withdrawal reflex, it can be modified via associative learning to respond to an 
initially irrelevant conditioned stimulus, which has been paired with the aversive 
unconditioned stimulus that normally elicits the UR (Gormezano et al., 1962). 
The simplest classical conditioning paradigm is delay conditioning, in which the 
inter-stimulus interval is relatively short and the stimuli co-terminate.  In a typical 
conditioning setup (Fig. 1), rabbits are presented with tone or light stimulation as the 
conditioned stimulus (CS, Fig. 1 – CS trace), which is paired with the subsequent 
presentation of a corneal air-puff or peri-orbital shock as the unconditioned stimulus (US, 
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Fig. 1 – US trace).  After repeated paired presentations of the CS and US, rabbits start to 
respond to the CS with an eyeblink conditioned response (CR, Fig. 1 – CR trace) in 
anticipation of the upcoming US. 
 
Fig.1. Schematic representation of the delay classical conditioning paradigm. 
 
Circuits subserving classical conditioning of the eyeblink response in the rabbit  
Studies conducted during the past three decades have revealed that acquisition and 
expression of classically conditioned responses is controlled by a neural network consisting 
of the intermediate cerebellum and several associated brainstem structures (Bracha and 
Bloedel, 1996; Mauk and Donegan, 1997; Christian and Thompson, 2003; Steinmetz, 2000; 
Gerwig et al., 2007).  To identify the function of individual components of this circuit, 
investigators used several different techniques, such as lesioning, electrophysiological 
450ms
CR (trained animal)
CS
US
350ms
100ms
UR (naïve animal)
CS US
CR UR
Unconditioned response (UR)
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recording, electrical stimulation and pharmacological inactivation.  It was shown that 
permanent lesioning or local inactivation of any component illustrated in Fig. 2 prevents 
acquisition of new CRs and abolishes expression of previously acquired CRs.  Furthermore, 
electrophysiological recordings have demonstrated that activity in these neuronal substrates 
correlates with the presented stimuli and with CR expression.  The inferior olive is a unique 
structure that responds to the US, and it has a very low frequency of neuronal activity (2-5 
Hz, Llinas et al., 2002).  The IO’s function in eyeblink conditioning was the subject of this 
thesis. 
 
 
Fig.2. Schematic representation of the cerebellar portion of circuits controlling 
classical conditioning of eyeblink responses 
Tone
Pontine Nuclei
Mossy 
fibers
Cerebellar 
Cortex
Interposed Nuclei
Climbing 
fibers
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?
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1.4.2 Cerebellar learning hypothesis 
After empirical identification of the brain structures that are essential for eyeblink 
conditioning (Fig.2), several hypotheses were formulated to explain the operation of this 
circuit and to propose possible sites of plasticity responsible for CR acquisition and retention.  
The most commonly discussed in the literature is the cerebellar learning hypothesis.  
According to this hypothesis, the cerebellar cortex and interposed nuclei are necessary and 
perhaps sufficient sites of plastic changes for acquisition and retention of discrete CRs in 
multiple effector systems (e.g., eyeblink, limb flexion).  The theoretical basis for this 
hypothesis of motor learning via synaptic plasticity in the cerebellum is derived from early 
concepts postulated by Marr (1969) and Albus (1971).  It is now assumed that information 
about the CS arrives to the cerebellum through mossy fibers originating in pontine nuclei 
(Steinmetz and Sengelaub, 1992).  Mossy fibers project to granule and Golgi cells in the 
granular layer of the cerebellar cortex as well as to the deep nuclei (McCrea et al., 1977).  
Granule cells send axons to the molecular layer of the cortex where they bifurcate to form 
parallel fibers.  Oriented longitudinally through cerebellar folia, parallel fibers interact with 
the dendritic field of Purkinje cells, making multiple synaptic contacts.  At the same time, 
information about the US is thought to be conveyed through climbing fibers originating in 
the inferior olive and projecting both to the molecular layer of the cerebellar cortex, 
intertwining with Purkinje cells’ dendritic field, as well as to the deep nuclei.  Thereby, the 
sensory information from mossy and climbing fibers converges on cortical Purkinje cells and 
cerebellar nuclear cells (Ito, 1984).  According to the cerebellar learning hypothesis, 
plasticity related to associative learning occurs as a result of this co-activation of mossy and 
climbing fibers.  It is presumed that the heterosynaptic interaction at the points of stimulus 
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convergence triggers local cellular plastic processes resulting in the changed responsivity of 
Purkinje and nuclear cells to the CS.  These plastic changes result in the network responding 
to the CS signal by issuing a cerebellar nuclear “motor command” that triggers the CR 
(Thompson, 1988; Thompson et al., 1997).  These command-oriented discharges are 
expected to strongly correlate with the amplitude-time course of conditioned eyeblinks. 
Indeed numerous studies seem to support the cerebellar learning hypothesis.  It was 
shown that inactivating the cerebellar cortex prevents CR acquisition (Hardiman et al., 1996; 
Attwell et al., 2001) and abolishes CR retention (Gruart and Yeo, 1995) in rabbits.  Recently 
it was found that inactivating the cerebellar cortex right after conditioning disrupts memory 
consolidation processes and thus prevents learning (Attwell et al., 2002).  Likewise, 
inactivating the IN or blocking protein synthesis in the IN prevents acquisition (Krupa and 
Thompson, 1997; Bracha et al., 1998) and abolishes CR expression (Chapman et al., 1990; 
Bracha et al., 1994).  Purkinje cells in the cerebellar cortex and neurons in the IN exhibit 
neuronal activity that precedes and correlates with behavioral CRs (Berthier and Moore, 
1990; Aksenov et al., 2004; Aksenov et al., 2005).  These findings are consistent with the 
idea that the cerebellar cortex and IN become responsive to the CS and generate the CR 
motor command that is sent to eyeblink motoneurons (Thompson, 1986; Green and 
Steinmetz, 2005). 
Although these experiments are consistent with the cerebellar learning hypothesis, 
they could not exclude involvement of other neuronal structures outside of the cerebellar 
circuit, e.g., cerebellar efferent targets.  It is possible that lesions or pharmacological 
manipulations of the cerebellum disrupt learning and memory by disrupting plastic changes 
at extra-cerebellar sites. 
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1.4.2 Inferior olive and the controversy about its functional role in associative 
learning and memory 
The inferior olive is a unique structure that projects exclusively to the cerebellum, and 
whose axons are the sole source of a distinct cerebellar input - the climbing fibers (Desclin, 
1974).  Experimental evidence suggests that the dorsal accessory IO is required for the 
acquisition and expression of classically conditioned eyeblinks (McCormick et al., 1985; 
T:urker and Miles, 1986; Yeo et al., 1986; Welsh and Harvey, 1998; Medina et al., 2002; 
Mintz et al., 1994).  Two competing hypotheses - the cerebellar learning hypothesis and the 
tonic regulation hypothesis - have been advanced to explain the data from the above studies. 
Cerebellar learning hypothesis.  According to the cerebellar learning hypothesis, the 
IO input to the cerebellum supplies “teaching” signals, which provide information about the 
US to learning substrates in the cerebellum.  This hypothesis predicts that removal of the IO 
should prevent CR acquisition.  Moreover, removing IO input in trained animals should be 
equivalent to removing the US, which would lead to the gradual disappearance or extinction 
of CRs.  So, one of the most straightforward tests of the cerebellar learning hypothesis 
involves eliminating the IO input to the cerebellum while examining the fate of previously 
learned CRs. 
Tonic regulation hypothesis.  According to the tonic regulation hypothesis, the 
function of the IO is to regulate tonic activity in the cerebellum.  This hypothesis predicts 
that inactivation of the IO would disrupt normal intrinsic activity in the cerebellum 
(Benedetti et al., 1983; Batini et al., 1985), which would prevent CR acquisition in naïve 
subjects and cause immediate abolition of CRs in trained rabbits (Yeo et al., 1986; Welsh and 
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Harvey, 1998).  Also see section “Blocking synaptic inputs in the IO and its effects on the 
cerebellum.” 
Conflicting data 
Testing predictions of the above two hypotheses about IO function has proven to be a 
complex issue.  While there is general agreement that rabbits need their IO to acquire and 
express eyeblink CRs, conflicting reports have emerged on the timing of CR abolition after 
IO inactivation, which is critical for discriminating between the competing IO hypotheses.  
McCormick et al. (1985) reported that IO electrolytic lesions abolish CRs gradually during 
several training sessions.  Their findings were supported by Medina et al. (2002), who 
inactivated the IO with the glutamate receptor antagonist, NBQX, which abolished CRs 
gradually over one training session.  Since gradual CR abolition resembles behavioral 
extinction, these findings were viewed as supporting the cerebellar learning hypothesis. 
Observations of gradual CR abolition have been contradicted by reports indicating 
that CR suppression ensues immediately following IO electrolytic lesioning (Yeo et al., 
1986) or lidocaine inactivation (Welsh and Harvey, 1998).  An immediate onset of this CR 
performance deficit is consistent with earlier studies demonstrating that electrolytic lesioning 
or cooling of the IO produces dramatic shifts of tonic activity in the cerebellar cortex 
(Montarolo et al., 1982; Batini et al., 1985; Demer et al., 1985), cerebellar nuclei (Benedetti 
et al., 1983) and even the red nucleus (Billard et al., 1988).  Since normal activity in 
cerebellar nuclei is required for CR expression (Aksenov et al., 2004), blocking CRs could be 
a simple consequence of IO inactivation-induced tonic dysfunction of cerebellar circuits. 
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Determining the precise role of the IO in eyeblink conditioning circuits is pivotal for 
confirming or disproving the cerebellar learning hypothesis, which is the key to 
understanding eyeblink conditioning.  Technical discrepancies among the differing studies 
reporting on the timing of CR deficits can only be reconciled by further experimentation.  
Early electrolytic lesion studies could have inadvertently disrupted axons passing in the IO’s 
vicinity, and may have suffered from a gradual post-lesion degeneration of the IO or its 
afferent sources.  Both of these phenomena could have affected the time course of 
developing CR deficits.  Similarly, inactivating the IO with lidocaine could have blocked 
passing axons thus confounding the effects specific to IO inactivation.  Another weakness 
inherent to the previous studies was that they did not examine effects of IO manipulations on 
cerebellar physiology.  The most likely reason for this omission was the lack of suitable 
methods for long-term recording of single-unit activity in awake animals. 
The main contribution of the present thesis is that we conducted a systematic series of 
experiments aimed at surmounting the shortcomings of previous studies.  Specifically, we 
developed pharmacological protocols for blocking specific synaptic inputs to the IO without 
affecting fibers of passage or the long-term survival of IO neurons.  Also, we were the first to 
perform critical measurements characterizing the shifts in cerebellar single-unit activity 
induced by IO manipulations in awake rabbits. 
Blocking synaptic inputs in the IO and its effects on the cerebellum 
The selection of appropriate drugs for blocking the IO sensory inputs and possible 
interpretations of cerebellar neuronal changes induced by their application are both facilitated 
by the known aspects of IO physiology. 
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The IO has a unique anatomical organization.  Its neurons are electrotonically 
coupled, forming gap-junctions (Llinas et al., 1974; Sotelo et al., 1974).  The IO has a 
relatively low frequency of neuronal activity, spontaneously discharging at 2-5 spikes/second 
(Leznik and Llinas, 2005).  The IO consists of several subnuclei that project contralaterally to 
para-sagittal zones of the cerebellar cortex (Azizi and Woodward, 1987), and they send 
collaterals to deep cerebellar nuclei that also receive Purkinje-cell projections from the same 
zone (Kitai et al., 1977; Bernard, 1987; Buisseret-Delmas, 1988; Voogd and Ruigrok, 2004 
;Ruigrok and Voogd, 2000; De Zeeuw et al., 1997).  It has been shown that only the rostro-
medial part of the dorsal accessory subnucleus is involved in eyeblink classical conditioning 
(Mauk et al., 1986; Yeo et al., 1986; Sears and Steinmetz, 1991).  The climbing fibers from 
this part of the IO project to Purkinje cells in the HVI zone of the cerebellar cortex, whose 
inhibitory fibers terminate in the anterior IN (Bishop et al., 1979; Furber and Watson, 1983; 
Andersson and Hesslow, 1987; De Zeeuw et al., 1997).  The IN then sends GABAergic 
projections to the IO, forming an inhibitory feedback within the olivocerebellar loop 
(Andersson et al., 1988; Fredette and Mugnaini, 1991; Buisseret-Delmas and Angaut, 1993; 
Svensson et al., 2005).  It has been suggested that the function of cerebellar-olivary inhibition 
might be to regulate synaptic plasticity resulting from parallel fiber/climbing fiber interaction 
in cerebellar Purkinje cells, by suppressing the IO after learning has occurred (Hesslow and 
Ivarsson, 1996; Bengtsson and Hesslow, 2006). 
Besides inhibitory inputs, the dorsal accessory IO receives excitatory glutamate 
afferents transmitting US information from the trigeminal nuclei (Huerta et al., 1985; van 
Ham and Yeo, 1992).  The presence of both GABA- and glutamate-ergic inputs offers two 
possible approaches to blocking IO input to the cerebellum.  One could utilize GABA-A 
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agonists to inactivate the IO, or glutamate antagonists to block its excitatory sensory inputs.  
Here we tested both approaches, using the GABA-A agonist, muscimol, and the glutamate 
antagonists, DGG and NBQX.  The feasibility of this approach is supported by previous 
studies having shown that local injections of GABA and glutamate antagonists alter IO 
activity and its responses to facial stimulation in anesthetized rats (Lang, 2001; Lang, 2002) 
and that IO infusions with NBQX abolish CRs in the rabbit (Medina et al., 2002). 
1.4.3 Testing the cerebellar learning hypothesis by blocking IO sensory input 
while maintaining its tonic activity  
Experiments described in Chapters 2 and 3 supported the tonic regulation hypothesis 
of IO function.  Does confirming that the IO regulates tonic cerebellar activity disprove the 
alternate cerebellar learning hypothesis?  Not necessarily.  The problem is that the two 
hypotheses do not have to be mutually exclusive.  In fact, some investigators have proposed 
that the IO plays a role both in learning CRs and in regulating cerebellar tonic activity 
(Bengtsson and Hesslow, 2006).  If this proves true, then demonstrating that IO blocking 
abolishes CRs via cerebellar tonic dysfunction (as shown in Chapters 2 and 3) would not 
constitute direct evidence against the cerebellar learning hypothesis.  This brings us to a 
fundamental question: Can these two putative functions be dissociated and tested 
independently? 
We hypothesize that the teaching function could be dissociated from the tonic 
function by independently manipulating the IO’s baseline firing that regulates cerebellar 
tonic activity and the IO’s evoked responses to sensory stimulation that were proposed to 
convey the error signal.  Thus, the ideal test of the cerebellar learning hypothesis would 
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involve examining behavioral and electrophysiological consequences of blocking the US 
input to the IO without affecting its intrinsic activity.  In the ongoing preliminary 
experiments described in Chapter 4, we have been examining this issue using a combined 
application of glutamate blockers and two drugs - harmaline and gabazine - that could 
potentially rescue the IO’s spontaneous firing. 
Systemic administration of the alkaloid, harmaline, produces synchronized rhythmic 
activation of IO neurons and induces a strong body tremor (De Montigny and Lamarre, 1975; 
Llinas and Volkind, 1973).  Recordings from the IO during systemic harmaline injections 
revealed synchronized rhythmic activation in the caudal half of the medial dorsal accessory 
IO (De Montigny and Lamarre, 1975).  The exact mechanism by which harmaline activates 
the IO has not been identified.  The second drug candidate for restoring IO activity is 
gabazine, a GABA-A receptor antagonist (Ueno et al., 1997).  Application of GABA 
antagonists has been previously shown to increase IO firing rates (Lang, 2002).  Effects of 
these two drugs on the recovery of CRs abolished by a prior injection of the glutamate 
antagonist DGG were examined in experiments described in Chapter 4. 
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CHAPTER 2.  INFERIOR OLIVARY INACTIVATION ABOLISHES 
CONDITIONED EYEBLINKS: EXTINCTION OR CEREBELLAR 
MALFUNCTION? 
A paper published in the journal “Behavioral brain research” 1 
S. Zbarska2,3, E.A Holland2, J.R. Bloedel2 and V. Bracha2,4 
2.1 Abstract 
The inferior olive (IO) is a required component of neural circuits controlling the 
classical conditioning of eyeblink responses.  Previous reports indicated that lesioning or 
inactivating the IO abolishes conditioned eyeblinks (CRs), but there was disagreement 
regarding timing of the CR performance deficit.  As a result, it was not clear whether IO 
inactivation produces unlearning of CRs or a non-specific dysfunction of cerebellar circuits.  
Since most of these studies used methods that could block unrelated axons passing through 
the IO region, additional experiments are required to further elucidate IO function, using 
inactivating agents that act selectively on cell bodies.  In the present study, the IO was 
inactivated using the glutamate receptor antagonist DGG and the GABA-A receptor agonist 
muscimol in rabbits performing well-learned CRs.  Effects of inactivating the IO on CR 
expression and on neuronal activity in the anterior cerebellar interposed nucleus (IN) were 
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2 Department of Biomedical Sciences, Iowa State University. 
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examined.  We found that either blocking excitatory glutamate inputs or activating inhibitory 
GABA inputs to the IO abolished CRs.  This effect occurred with variable delay following 
drug injections.  Additional experiments, in which post-injection testing was delayed to allow 
for drug diffusion, revealed invariably immediate suppression of CRs.  This demonstrated 
that suppressing IO activity using DGG or muscimol does not induce unlearning of CRs.  
Single-unit recording during DGG injections revealed that CR suppression was paralleled by 
a dramatic suppression of IN neuronal activity.  We concluded that inactivating the rostral 
parts of the IO complex abolishes CRs by producing a tonic malfunction of cerebellar 
eyeblink conditioning circuits.  
2.2 Introduction 
Classical conditioning of the eyeblink response in the rabbit is a popular model for 
the study of implicit memory.  The acquisition and expression of classically conditioned 
eyeblink responses (CRs) is critically dependent on the intermediate cerebellum and 
associated circuits.  A pivotal component of these circuits is the inferior olive (IO) which is 
thought to supply the cerebellum with an unconditioned stimulus (US) signal that is required 
for both the learning and also for the maintenance of already acquired CRs [e.g. 21,30].  
However, the precise role of the IO remains unclear, mostly because of discrepancies in 
reports that examined effects of IO lesioning or inactivation on CR expression. 
The inferior olive (IO) is a unique structure that projects exclusively to the 
cerebellum, and the IO axons are the sole source of a distinct cerebellar input - the climbing 
fibers.  Evidence suggests that the dorsal accessory IO is required for the expression of 
eyeblink CRs.  For example, lesions of the dorsal accessory IO abolish previously established 
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CRs [30, 19].  Similar to effects of permanent lesions, suppressing IO activity with the 
sodium channel blocker lidocaine [28], or with the AMPA receptor antagonist NBQX [21], 
abolished CRs. 
While it is agreed that IO inactivation produces abolition of eyeblink CRs, reports on 
the timing of the CR performance deficit are conflicting.  Two studies reported that IO 
inactivation or lesioning abolishes CRs gradually over one [21] or several training sessions 
[19].  Since gradual CR abolition resembled behavioral extinction, these findings were 
viewed as supporting the cerebellar learning hypothesis, which assumes that the IO provides 
the cerebellum with the unconditioned stimulus (US) information.  According to this concept, 
blocking the IO prevents the US signal from reaching cerebellar substrates required for 
learning, thus leading to CR extinction. 
Observations of gradual CR abolition were contradicted by reports indicating that CR 
suppression ensues immediately following IO lesioning [30] or inactivation [28].  An 
immediate onset of this CR performance deficit is consistent with earlier suggestions that the 
IO regulates tonic activity in the cerebellum [2, 22].  These authors reported that inactivating 
the IO increases tonic activity of cerebellar cortical Purkinje cells, thereby suppressing 
neuronal activity in deep cerebellar nuclei.  Since normal activity in cerebellar nuclei is 
required for CR expression [1], blocking CRs could be a simple consequence of IO 
inactivation-induced tonic dysfunction of cerebellar circuits. 
Due to these discrepancies in experimental findings, the precise role the IO plays in 
CR control remains unclear.  The differing reports on the timing of CR performance deficits 
are associated with divergent interpretations of IO function and are difficult to reconcile 
without further experimentation.  Early electrolytic lesion studies could have been affected 
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by inadvertent disruption of axons passing in the IO vicinity or by a gradual post-lesion 
degeneration of the IO or its afferent sources.  Both of these phenomena could have affected 
the time course of developing CR deficits.  Similarly, inactivating the IO with lidocaine 
could have blocked passing axons thus confounding effects specific to IO inactivation. 
To resolve these issues, we designed experiments whose objective was to reversibly 
inactivate the IO without affecting fibers of passage in rabbits producing well-learned CRs.  
The unique feature of these experiments is that they combine, for the first time, selective 
pharmacological manipulation of the IO with simultaneous behavioral and 
electrophysiological analysis.  Since understanding the behavioral effects of IO 
manipulations depends on knowing the impact of these treatments on cerebellar activity, we 
combined the behavioral measurements of CRs with electrophysiological recordings of 
cerebellar nuclear activity.  We hypothesized that suppressing neuronal activity in the 
contralateral dorsal accessory IO abolishes CRs due to a tonic malfunction of cerebellar 
eyeblink conditioning circuits. 
It is known that the IO receives inhibitory GABA and excitatory glutamate afferents 
and those local injections of GABA and glutamate receptor antagonists alter IO activity in 
anesthetized rats [16, 17].  Thus, either GABA receptor agonists or glutamate receptor 
antagonists could be used to suppress IO activity.  Here we report effects of microinjecting 
the GABA-A receptor agonist, muscimol, and the glutamate AMPA/kainate and NMDA 
receptor antagonist, DGG, in the IO of rabbits exhibiting well-learned CRs.  We found that 
both drugs abolished CRs with a variably delayed effect.  Introducing a short waiting period 
to allow for drug diffusion following drug injections produced an immediate abolition of 
CRs.  Exploratory recordings of neuronal activity in cerebellar interposed nuclei (IN) 
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demonstrated that blocking glutamate neurotransmission in the IO leads to decreased IN 
neuronal firing rates.  These results indicate that inactivating the dorsal accessory IO 
abolishes CRs via the tonic dysfunction of neuronal activity in the intermediate cerebellum.   
This paper has been previously presented in abstract form [31]. 
2.3 Materials and Methods 
2.3.1 Subjects 
Eleven male, New Zealand White Rabbits (Harlan, Indianapolis, Indiana), weighing 
2.5-3.0 kg (3-4 months old at the beginning of experiments), were used in these studies.  
Eight rabbits were included in a study examining effects of IO inactivation on CR expression 
(IO injection group).  The remaining three animals were used in experiments testing effects 
of IO inactivation on CRs and on neuronal activity in the IN (IN recording group).  Rabbits 
were housed individually on a 12/12 hr light/dark cycle and provided with food and water ad 
libitum.  All experiments were performed in accordance with the National Institutes of 
Health’s “Principles of Laboratory Animal Care” (publication No. 86-23, revised 1985), the 
American Physiological Society’s “Guiding Principles in the Care and Use of Animals,” and 
the protocol approved by Iowa State University’s Committee on Animal Care. 
2.3.2 Surgery 
Surgical implantation of injection and recording hardware was performed on naïve 
animals using sterile surgical techniques.  Rabbits were anesthetized with a mixture of 
ketamine (50 mg/kg), xylazine (6 mg/kg), and acepromazine (1.5 mg/kg) and placed in a 
stereotaxic apparatus with lambda positioned 1.5 mm below bregma.  After exposing the 
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skull, three stainless steel anchor screws and a 28-gauge injection guide tube were implanted.  
For targeting anterior parts of the right IO, the following stereotaxic coordinates (relative to 
lambda) were used: AP=x-(0.69x+4.5) mm (x is horizontal distance between bregma and 
lambda in mm), ML=1.0 mm and DV=22.4 mm.  The patency of the injection guide tube 
between experiments was protected by a 33-gauge stainless steel stylet.  
The three rabbits in the IN recording group were also implanted with a 
microelectrode array/micromanipulator assembly targeting the left IN as in [1].  The 
manipulator contained three bundles of microwire electrodes totaling 14 electrodes (stainless 
steel, 18 µm diameter, Formvar insulation).  The microwires were connected to a 15-pin 
connector embedded in dental acrylic.  The stereotaxic coordinates for the IN implant were: 
AP=x-(0.69x+4.8) anterior to lambda (x is distance between bregma and lambda in mm); 
ML=5.0 mm lateral to lambda, and DV=14 mm ventral to lambda.  The guide tube, 
manipulator, connector, anchor screws, and a small Delrin block designed to accommodate 
an air-puff delivery nozzle and an eyeblink sensor were secured in place with dental acrylic.  
Following surgery, the manipulator and injection guide tube were protected with removable 
Delrin caps.  All animals were treated with antibiotics during a 5-day post-surgical recovery 
period.   
2.3.3 Training procedures 
Before any training began, all rabbits were first adapted to a restraint box in a sound-
attenuated experiment chamber for 3 days, 30 min per day.  Head movements were not 
restricted either during adaptation or during experiments.  Adapted animals were conditioned 
in the standard delay classical conditioning paradigm until they reached 90% of conditioned 
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responses (CRs) for at least two consecutive days.  The conditioned stimulus (CS) was a 
binaural 450-ms, 80-dB SPL, 1-kHz tone, superimposed on a 70-dB white noise.  As 
unconditioned stimulus (US), a 100-ms, 50-psi (at the source) air puff was applied to the left 
eye.  The inter-stimulus interval was 350 ms.  The inter-trial interval varied from 15 to 25 s 
pseudo-randomly.  Each rabbit had one conditioning session of 100 paired trials per day.   
2.3.4 Injection procedures 
Before each injection experiment a 33-gauge stainless steel needle was inserted in the 
guide tube.  The injection needle was connected to a 10-µl Hamilton syringe using 
transparent Tygon tubing.  The intracranial microinjections were performed manually at a 
rate of 0.5 µl/min.  The injected volume was monitored by observing the movement of a 
small air bubble relative to gradation marks on the transparent tubing.  During injection 
sessions, 40 trials of paired stimuli were applied prior to the injection to assure that needle 
insertion had no effect on CR performance.  Drugs were not injected if rabbits had less than 
85% CRs during the pre-injection baseline period.   
Injection experiments were conducted in two stages.  The first was the functional 
mapping stage when the effective depth for injections was determined.  In the second stage of 
injection experiments, effects of drugs on CR performance were measured and compared.  
Since previous studies have shown that AMPA receptor blockers decrease neuronal activity 
in the IO [17] and abolish eyeblink CRs [21], we used 1.0-µl injections of the AMPA/kainate 
and NMDA receptor blocker, DGG (Tocris Bioscience, 100 nmol in 1µl), for functional 
mapping.  During the mapping stage, the first exploratory DGG injection was performed at 
the depth of the guide tube tip.  If no effects on CR incidence were observed, the animal was 
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injected 0.5 mm deeper the next day.  This daily increase of injection depth was repeated 
until the DGG injection completely abolished CRs.   
Once the effective injection site was determined, the second stage of the experiment 
ensued.  Sessions at this stage consisted of 40 pre-injection trials and 120 post-injection 
trials, which were administered without delay immediately following the injection.  Since 
CRs were abolished gradually in most rabbits, all animals were tested in additional sessions 
that included a waiting interval following the injection and before resuming CS-US 
stimulation trials.  The purpose of this waiting interval was to allow for effective drug 
diffusion before trials resumed.  The duration of this waiting interval in each rabbit was equal 
to the time it took to abolish CRs in its previous no-waiting session.  In the three rabbits from 
the IN recording group, the post-injection period lasted either until the drug effect recovered, 
or until 260 trials.   
On days following successful DGG injections, rabbits were injected either with 1.76 
nmol in 0.5 µl of the GABA-A receptor agonist, muscimol (MP Biomedicals (formerly ICN), 
or with a control injection of the corresponding volume of vehicle.  In two rabbits with the 
most rostral placement of injection needles, the volume of muscimol was increased to 1 µl 
because the original drug amount did not suffice to completely abolish CRs.  In addition, 
effects of all drugs were measured in waiting period experiments (see above).  All drugs were 
dissolved in artificial cerebrospinal fluid (aCSF, [21]) and their pH was adjusted to 7.4"0.1.  
Only one drug was injected on any given experiment day.  
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2.3.5 Data recording and analysis  
In the IO injection group, the eyeblink was recorded using an electro-mechanical 
lever system coupled to the upper eyelid before each session [7].  In rabbits from the IN 
recording group, eyeblinks were measured using a new, wide field-of-view infrared sensor 
[23].  The output of sensors was amplified, digitized at 1 kHz with 12-bit resolution, and 
displayed and stored on a custom data acquisition system.  Data were acquired for 1400 ms 
in each trial, starting 250 ms before CS onset.  Eyeblink responses in the time frame between 
80 ms after CS onset and US onset were considered CRs when they exceeded the mean of the 
signal in the 250-ms baseline period by more than five standard deviations (approximately 
0.1 mm).  This relatively low threshold was selected to capture small responses that could be 
present during an incomplete drug effect or when the drug effect starts to recover.  
Spontaneous responses were defined as trials in which the difference between the maximum 
and minimum values in the baseline period exceeded 0.5 mm.  Any blink exceeding the CR 
threshold within 80 ms after CS onset was recognized as an alpha response.  Trials 
containing spontaneous blinks or rare alpha responses were stored but were not included in 
further data analyses.  Measurements of eyeblink responses were used for calculations of CR 
incidence per block of 10 trials in each session.   
In addition to the visualization of eyeblink traces on the computer monitor, two video 
cameras were installed in the experiment chamber to monitor general animal behavior during 
experiments.  One camera provided a front view of the rabbit’s head and the other one was 
positioned on the side of the trained eye.  This setup proved to be invaluable for detecting 
drug injection side effects.   
 36 
 
In the IN recording group, multiple single-unit signals from microwire electrodes 
were fed through a custom miniature 14-channel FET-based preamplifier to a multi-channel 
differential amplifier system (Grass-Telefactor model 12 Neurodata System).  The amplified 
and bandpass-filtered (300 Hz-3 kHz) signal was digitized (25 kHz/channel) using a custom 
data acquisition system, and was displayed and stored in 1400-ms epochs corresponding to 
individual trials.  Unit discrimination was performed offline using threshold detection 
followed by a cluster analysis of scatter plots of time and amplitude distances between the 
peak and valley of individual action potential waveforms.  The discriminated data were 
processed using custom software in addition to a commercial data analysis package 
(NeuroExplorer, Nex Technologies).  Cross-correlation analysis was performed for each unit 
to eliminate multiple inclusions of the same unit recorded on different wires within a bundle.  
Raster and peri-event histograms were constructed for each unit.  Separate histograms were 
constructed for baseline trials, trials after the injection, and trials at the end of session 
representing recovery.  In each histogram, the baseline firing rate (250 ms before CS onset) 
and the timing of significant excitatory and inhibitory changes were computed.   
Baseline means of individual cell histograms were pooled together within DGG and 
control experiments and statistically analyzed.  Only units that were isolated reliably 
throughout the experiment, as judged by the invariance of the shape and size of action 
potentials, were included in the data analysis.   
For the statistical analysis, we used repeated measures ANOVA with the following 
factors: drug (3 levels: drug, drug with delay, and aCSF) and time/dose (3 levels: before 
injection, after injection, and recovery).  The repeated factor was the four 10-trial blocks that 
comprise each phase of an experiment.  For the analysis of IN group cell activity, the 
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ANOVA included an additional blocking factor (rabbit) to account for multiple cells 
recorded from the same animal.  We generated planned contrasts from the ANOVAs to 
address hypotheses regarding patterns of CR incidence and baseline activity of IN neurons 
arising from the interaction between treatments and phases of experiment.  Specifically, 
using groups of 10-trial blocks, we performed 1-df contrasts between pre-injection, post-
injection and recovery within and between experiments with no time delay, with time delay, 
and their controls.  All group data are reported as mean ± standard error of the mean.  All 
statistical analyses were performed using Statsoft Statistica software.   
2.3.6 Histology 
After all experiments were completed, rabbits were deeply anesthetized with a 
mixture of ketamine (50 mg/kg), xylazine (6 mg/kg), and acepromazine (1.5 mg/kg).  The 
injection site was marked by injecting 1 µl of tissue-marking dye.  Anesthetized animals 
were transcardially perfused with 1 L of phosphate-buffered saline followed by 1 L of 
fixative (10% buffered formalin) and 1 L 10% potassium ferrocyanide in 10% formalin.  The 
potassium ferrocyanide was applied only to IN-recording rabbits, where the location of 
electrodes was marked by passing 10 µA anodal DC current through each wire for 20 s.  
Whole brains were removed and placed in a solution of 30% sucrose and 10% formalin.  One 
week later, brains were sectioned coronally at 50 µm on a freezing microtome.  Sections 
were mounted onto gelatin-coated slides, dried, and stained with either Luxol blue and 
neutral red (IO injection group) or with ferrocyanide hydrochloride and neutral red (IN 
recording group).  Locations of the injection sites were determined using bright field 
microscopy and transferred to a standardized set of coronal sections of the rabbit medulla.  
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Locations of electrode marks were transferred to a standardized set of coronal sections of the 
rabbit cerebellar nuclear region. 
2.4 Results 
2.4.1 Location of injection sites and general observations 
The histological reconstruction of injection sites in the IO injection group revealed 
that they were located in the close vicinity of the rostral portion of the inferior olivary 
complex (Fig.1).  The ranking of injection sites based on the rate of the drug-induced CR 
abolition indicated that the most effective injection sites were just dorsal or within the dorsal 
accessory olive; rostro-caudally, these sites were also closest to the most rostral pole of the 
medial accessory olive (Fig. 1 D and E).   
All rabbits in the IO injection group reached the 90% CR criterion in 6 to 18 sessions.  
The mean CR incidence was 91.4±1.7% and 91.1±0.6%, respectively, in the last two training 
sessions.  Once effective injection sites were established, microinjections of both DGG and 
muscimol reliably abolished CRs, albeit with a variable delay (see sections 3.2 and 3.3 for 
additional information).  Besides the suppression of CRs, additional side-effects of both 
drugs were observed.  In general, at the given drug concentrations and volumes, muscimol 
yielded stronger behavioral effects than did DGG.  Thus, to minimize the spatial extent of 
inactivation, a smaller volume of muscimol (0.5 µl) was used when sufficient to abolish CRs.  
In most experiments, increased tonic eyelid aperture was detected following muscimol and 
DGG injections.  Two subjects with the most laterally placed injection sites exhibited 
bilateral nystagmus, head rotation to the right, and a postural asymmetry characterized by 
limb extension on the right side of the body once released from the restraint box.  Four 
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Fig. 1.  Location of injection sites in the IO injection group (●, n=8) and in the IN 
recording group ( , n=3).  The identified sites in individual animals were transferred to a set 
of standardized coronal sections of the rabbit medulla, arranged in rostral-to-caudal order (A-
H).  All injection sites were found within or close to the rostral part of the inferior olivary 
complex.  Injections of DGG at all marked sites abolished CR expression.  The animals were 
ranked based on the aggregate rate of the DGG- and muscimol-induced CR abolition (fastest 
effect was ranked 1), and their rank is indicated by the number associated with each injection 
site mark.  The anterior-posterior distance of each section from the most rostral pole of the 
IO in mm is labeled on the lower right side of individual sections.  IOD - dorsal accessory 
inferior olive; IOM - medial inferior olive; IOPr - principal inferior olive; IOA - subnucleus 
A of the medial inferior olive; IOB - subnucleus B of the medial inferior olive; IOK - cap of 
Kooy of the medial inferior olive; Sp5N - spinal trigeminal nucleus; sp5 - spinal trigeminal 
tract; Pr - prepositus hypoglossal nucleus; 7N - facial nucleus; icp - inferior cerebellar 
peduncle; MVe - medial vestibular nucleus; SolN - solitary nucleus; AmbC - ambiguous 
nucleus; 12n - hypoglossal nerve; 10N - dorsal motor nucleus of the vagus; DCN – dorsal 
cochlear nucleus. 
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rabbits exhibited short periods of sneezing after drug injections.  While the timing of eyelid 
opening usually paralleled effects on CRs, other behavioral effects such as nystagmus and 
head rotation developed later during the experiment.  All of these effects were more 
pronounced following muscimol injections, indicating that this drug inactivated a larger area 
of the brain or produced more complete local inactivation.  
2.4.2 Effect of DGG on CR expression 
Immediate post-injection test.  Injecting the AMPA/kainate and NMDA receptor 
blocker, DGG, at effective injection sites abolished CR expression.  Typically, rabbits 
exhibited high CR incidence during the 40 trials before injection, then during post-injection 
trials CRs gradually disappeared (Fig. 2 A); in the example illustrated in Fig. 2 A, the effect 
did not recover during the 80 post-injection trials.  Injections of the vehicle at the same site 
had no effect on CR incidence (Fig. 2 C).   
The onset of CR abolition varied between rabbits from an immediate effect to 
approximately 15 min after the drug injection.  Recovery of CRs at the end of an injection 
session was observed in three out of eight rabbits.  Pooled data from eight IO injection 
animals revealed that CR incidence gradually decreased from 87.5±6.2% in the first post-
injection block of 10 trials to 2.5±1.6% in the fifth post-injection block (Fig.3 A).  During the 
last block of trials, CR incidence was 7.5±4.1% (Fig.3 A).  This decline of CR frequency 
contrasted with stable CR performance in the control experiment before and after vehicle 
(Fig. 3 A).  The repeated measures ANOVA yielded significant drug effects.  While the 
planned comparisons revealed a significant effect of DGG (F1,63=110.668, p<0.05) when 
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Fig. 2.  Individual examples of behavioral effects of microinjecting DGG and vehicle 
(aCSF) into the IO of the same subject.  Each stack plot represents a complete printout of 
eyeblinks from a 120-trial injection experiment.  The experiments start at the top, and each 
trace represents one trial.  Drug injections are denoted by an arrow in the each stack plot.  
Conditioned eyeblinks are upward deflections of the signal between the CS and US onset 
markers.  A: Eyeblinks in an experiment where CR testing was resumed immediately 
following the injection of 1.0 µl of DGG.  Note that CRs were gradually abolished shortly 
following the DGG injection.  B: Stack plot of eyeblink mechanograms in an experiment in 
which the eyeblink CR testing was delayed by inserting a waiting period for DGG diffusion.  
In this test, CRs were absent immediately after stimuli resumed, indicating that the delayed 
drug effect in part A was due to drug diffusion.  Note the partial recovery of CRs at the end 
of the waiting experiment.  C: Eyeblinks in the control experiment in which the injection of 
1.0 µl of vehicle (aCSF) did not affect CRs.  
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comparing pre-injection performance with CR incidence in all post-injection blocks, effects 
of vehicle were insignificant. 
The waiting period test.  The waiting period test was administered to examine the 
role of post-injection stimulation in the gradual abolition of CRs following DGG injections.  
It was expected that if gradual CR abolition in the previous non-waiting test represented CR 
extinction, then postponing the CS-US presentation following the DGG injection should have 
no effect on the timing of CR abolition.  This prediction was not confirmed.  Fig. 2 B 
illustrates that when a waiting period was inserted between the drug injection and post-
injection testing, CRs were absent immediately from the beginning of the post-injection test.  
In most waiting experiments, CRs partially recovered at the end of post-injection testing (Fig. 
2 B).   
At the group level, CR incidence precipitously declined from 84.0±3.3% in the last 
block of pre-injection trials to 1.3±1.3% during the first 10 post-injection trials (Fig. 3 A).  
Related to the extended period of observation after injections with wait periods, CRs tended 
to recover partially toward the end of these experiments, starting from the fourth post-
injection block of trials.  This recovery was observed in three out of eight rabbits with one of 
them illustrated in Fig. 2 B.  In the last 10-trial block of the waiting period test, mean CR 
incidence in the IO injection group was 25.0±13.6%.  The post-injection decline in CR 
incidence was significant both when compared to the pre-injection period (F1,63=128.580, 
p<0.05) and to the corresponding block of 40 post-injection trials in the non-waiting test 
(F1,63=12.086, p<0.05).  During the last 40 trials of the waiting period test CR incidence had 
partially recovered to 22.8±6.2%, which was significantly different from the corresponding 
block of trials in the non-waiting test (6.6±2.5 %, F1,63=4.523, p<0.05).   
 43 
 
 
Fig. 3.  Effects of DGG, muscimol, and vehicle on CR incidence (±SE) in the group 
of IO injection rabbits (n=8).  A: Effects of DGG when tested immediately following the 
injection (▲) and following the diffusion waiting period (□) are compared to those observed 
following the control injection of vehicle (○).  Injections (inj.) were administered between 
the fourth and fifth blocks of trials and are denoted by a vertical dashed line.  Note that up to 
4 blocks of trials were required to obtain complete CR abolition in the non-waiting test, while 
CRs were immediately absent in the first post-injection block of the waiting test.  B: Effects 
of muscimol injections in the same group of animals as in A.  When the effect of 0.5 µl - 1.0 
µl of muscimol was tested immediately following the injection (▲), CR incidence gradually 
declined until the end of testing. When the resumption of post-injection CS+US trials was 
delayed until after a pre-specified diffusion waiting period, CRs were immediately abolished 
(□).  Injection of vehicle (aCSF) did not affect CR incidence (○).  
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2.4.3 Effect of muscimol on CRs 
Immediate post-injection testing.  To examine effects of suppressing IO activity via 
activating local GABA receptors, microinjections of the GABA-A receptor agonist, 
muscimol, were administered at the same injection sites as DGG.  Similar to DGG, injections 
of muscimol gradually suppressed CRs (Fig.4 A).  Typically, the effect of muscimol was 
long-lasting, as the CR deficit recovered in only one rabbit (Figs. 4 A-B).  The onset of the 
muscimol-induced CR suppression appeared to be slower than that following DGG 
injections.  This slower effect relative to DGG could have been related to the smaller volume 
of muscimol injections, to a possible difference in diffusion rate, or to a more developed 
gliotic scar at the time of muscimol injections.  The onset of muscimol’s action varied among 
rabbits from an immediate effect to 20 min following the muscimol injection.  Across all 
animals, CR incidence gradually decreased from 80.0±10.4% in the first 10 post-injection 
trials to 8.75±8.75% in the seventh post-injection block (Fig. 3 B).  The repeated measures 
ANOVA indicated significant effects of drug and time.  CR incidence in all post-injection 
trials of the muscimol test was significantly smaller than the pre-injection level 
(F1,63=88.860, p<0.05) and the corresponding post-injection block of trials in the control 
experiment (F1,63=115.7868, p<0.05).   
The waiting period test.  Inserting a waiting period following muscimol injections to 
allow for drug diffusion had a clear effect on the timing of CR suppression (Fig. 4 B).  
Following the waiting period, CRs were absent immediately and remained abolished across 
all rabbits (Fig. 3 B).  Incidence of CRs dropped from 94.3±1.8% pre-injection to 2.5±1.6% 
immediately post-injection (Fig.3 B), and CRs remained essentially absent throughout the 
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first 40 post-injection trials (F1,63=212.902, p<0.05).  This immediate reduction of CR 
incidence contrasts with gradual abolition of CRs in the non-waiting test (F1,63=56.979, 
p<0.05).  Control injections of vehicle had no effects on CR expression (Figs. 3 B, 4 C).  
Fig. 4.  Individual example of muscimol-induced suppression of CRs.  Stack plots of 
all eyeblinks recorded in three separate experiments from the same animal.  A: Eyeblinks in 
an experiment where CRs were tested immediately following an injection of 1.0 µl of 
muscimol.  CRs were gradually abolished within 15 min of post-injection training.  B: 
Eyeblinks in an experiment where post-injection testing was delayed by a 15 min diffusion 
waiting period.  Note that CRs were absent starting from the first post-injection trial.  C: 
Control experiment.  Injecting 1.0 µl of vehicle did not suppress CR performance.  For 
additional information see the legend of Fig. 2.   
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2.4.4 Effect of DGG injection in the IO on cell activity in the IN 
To examine how blocking fast glutamate receptors in the IO affected cell activity in 
the IN, three additional rabbits were implanted with injection guide tubes in the contralateral 
IO and with microelectrodes in the IN ipsilateral to the trained eye.  The histological 
reconstruction revealed that all injection sites in these rabbits were located close to the rostral 
portion of the dorsal accessory olive (Fig. 1) and all recording sites were located in the IN or 
in the medial part of the dentate nucleus (Fig. 5).  
 
 
Fig. 5.  Reconstruction of cell recording sites in the IN.  Out of 9 electrode bundles in 
three rabbits, five were located in the IN and one in the lateral part of the dentate nucleus.  
Their position was transferred to a set of standardized coronal sections of the rabbit 
cerebellar nuclear region.  Sections are arranged in rostral-to-caudal order (A-D).  All 38 
recorded cells were distributed among the illustrated sites.  InA - anterior interposed nucleus; 
DN - dentate nucleus; LV - lateral vestibular nucleus; SV - superior vestibular nucleus; InP - 
posterior interposed nucleus; FN - fastigial nucleus; scp - superior cerebellar peduncle; icp - 
inferior cerebellar peduncle. 
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Fig. 6.  An example of parallel effects of DGG, both on CR performance and on the 
activity of the task-modulated IN cell.  This experiment consisted of 300 trials with the 
injection administered after 40 trials.  A: Stack plot of all eyeblinks before and after the DGG 
injection.  CRs were gradually abolished within 3 min following the drug injection.  
Recovery of CRs was observed at the end of the experiment.  B: Raster plot of IN cell 
activity during the same experiment.  The experiment starts at the top with each row 
representing one trial, and dots mark occurrence of action potentials.  Shortly after the 
injection and at the time of behavioral CR abolition, the firing rate and modulation of this 
cell’s activity were severely suppressed.  The neuronal activity slowly recovered toward the 
end of the experiment, with the signs of the recovery apparent before the recovery of 
behavior in A.  C: a peri-stimulus histogram of the same IN unit constructed for 40 trials 
before the injection.  This cell expressed a strong excitatory response during the CS-US 
interval followed by a post-US inhibition.  D: peri-stimulus histogram of the same cell as in 
B and C during 40 post-injection trials when behavioral CRs were abolished and cell activity 
was suppressed.  E: peri-stimulus histogram of the same cell during the last 40 trials when 
partial recovery of behavior and cell activity were observed.  Bin width for histograms in C, 
D, and E is 20 ms. CS, onset of conditioned stimulus; US, onset of unconditioned stimulus.   
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Figure 6 illustrates parallel effects of injecting 1.0 µl of DGG on CR expression and IN 
unitary activity.  Within this one representative experiment, the IN unit exhibited a 
combination of excitatory and inhibitory responses to the CS and US.  The DGG injection in 
the IO abolished CR expression (Fig. 6 A) while severely suppressing the baseline firing rate 
and modulation of the IN neuron (Figs. 6 B-D).  Toward the end of the session the behavioral 
effect partially recovered (Fig. 6 A), which was also accompanied by a partial recovery of the 
IN neuronal firing rate and modulation (Figs. 6 B, E).   
In total, 21 neurons were successfully held and recorded during DGG injections and 
17 neurons during injections of vehicle.  For the DGG cell population, the mean baseline 
firing rate decreased from 27.0±1.6 Hz pre-injection to 9.6±2.1 Hz in the first 10 trials post-
injection, then to 2.8±0.6 Hz by the third post-injection block (Fig. 7 A); this decrease was 
significant as shown by comparing the pre-injection rate with the stabilized activity during 
blocks 7-10 (blocks 3-6 post-injection) (F1,103=41.904, p<0.05).  Significant recovery of the 
baseline firing rate occurred during the last 40 trials (F1,103=5.971, p<0.05), but was 
incomplete relative to the pre-injection level (F1,103=16.238, p<0.05).  Activity of IN neurons 
was not affected by control injections of vehicle as the mean firing rate remained stable 
across all 10-trial blocks (Fig. 7 A).   
The DGG-induced decrease of IN neuronal activity slightly preceded and coincided 
with a gradual abolition of behavioral CRs.  Mean CR incidence significantly decreased from 
93.1±1.6% pre-injection to 14.4±2.2% in blocks 7-10 (F1,37=95.719, p<0.05, Fig.7 B).  
Similar to the neuronal activity, partial recovery of CR incidence was observed in the last 40 
trials of the recording session (Fig. 7 B), which was significant when compared to blocks 7-
10 (F1,103=22.398, p<0.05), but was incomplete relative to the pre-injection level  
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Fig. 7.  Group effects of DGG on CR performance and on IN activity during the first 
six post-injection blocks of trials and the last four blocks of trials.  The last four blocks of 
trials are separated from the rest of the plot by a gap.  A: Effects of DGG on mean baseline 
activity (±SE) of IN cells (n=21).  Spike frequency of IN cells gradually decreased within the 
first two blocks after injection of DGG into the IO (▲), and it was almost completely 
suppressed during the following four post-injection blocks of trials.  The cell activity 
partially recovered during the last four blocks of the experiment.  Injection of aCSF into the 
IO (○) had no effect on IN firing rate (n=17).  B: Effects of DGG (▲) on mean CR incidence 
(±SE; n=3) in the same set of experiments as depicted in A.  CRs were gradually abolished 
and then partially recovered by the end of testing.  This behavioral effect parallels changes in 
IN activity shown in A.  Control injections of vehicle (○) did not affect CR performance. 
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(F1,103=25.513, p<0.05).  These observations were contrasted with control experiments on the 
same subjects, in which injections of aCSF did not affect CR incidence (Fig.7 A).   The 
block-by-block analysis of individual cell and CR incidence changes revealed that in most 
neurons, the DGG-induced suppression of activity preceded the suppression of CRs.  
Baseline activity of fifteen neurons decreased to less than 50% of their pre-injection level 
during the first post-injection block, before CR performance declined significantly in those 
particular experiments.  Activity of four cells changed in parallel with the developing CR 
suppression, and only two cells began to change their activity after changes in CR incidence 
were detected.  
2.5 Discussion and Conclusions 
The data presented here demonstrate that activating GABA-A receptors or blocking 
the glutamate AMPA/kainate and NMDA receptors in the rostral parts of the inferior olive 
abolish the expression of well-learned eyeblink CRs in the rabbit.  Both muscimol and DGG 
abolished CRs after a variable time delay, ranging from an immediate effect to approximately 
15 minutes post-injection.  The most important finding of the present study was that the 
gradual disappearance of CRs was a function of time rather than of post-injection training.  
This was demonstrated by the absence of CRs when the delivery of stimuli was delayed to 
allow for drug diffusion.  Recordings of IN neuronal activity during the block of glutamate 
receptors in the IO further suggest that CR abolition was associated with a significant 
decrease of tonic activity in the deep cerebellar nuclei.   
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2.5.1 Involvement of the IO in expression of conditioned eyeblinks 
A unique feature of eyeblink conditioning in the rabbit is its dependency on the 
intermediate cerebellum.  Studies from several laboratories demonstrated that lesioning or 
reversible inactivation of the cerebellar interposed nuclei ipsilateral to the trained eye 
abolishes previously learned responses and also prevents acquisition of new CRs [20, 29, 27, 
6, 14].  The present data extend these findings by showings that either blocking the fast 
glutamate receptors or activating GABA-A receptors in the contralateral IO also abolishes 
CRs.  This finding is consistent with CR suppression reported following IO lesioning [30] or 
lidocaine inactivation [28].  We also found that the onset of the behavioral effect varied.  In 
some animals, CRs were abolished immediately following the injection.  In most cases, 
however, this effect was delayed for a variable length of time, creating the impression of an 
extinction-like gradual decrease of CR incidence.  To test whether this delay would depend, 
similar to behavioral extinction, on the post-injection presentation of stimuli, we re-examined 
the same animals in a waiting period test.  In this test, the post-injection training was delayed 
by a waiting period equal to the previously observed delay of behavioral effects.  Following 
the waiting period, CRs were absent when stimulation was resumed.  This finding revealed 
that CR abolition following muscimol and DGG injections does not require presentation of 
stimuli and therefore it can not be interpreted as analogous to behavioral extinction.  
Consequently, the most likely explanation for delayed muscimol and DGG effects was slow 
drug diffusion to the facial representation within the IO.   
The IO is somatotopically organized with respect to its somatosensory inputs.  The 
parts of the IO receiving somatosensory input from the contralateral facial area are the 
medio-rostral parts of the dorsal accessory olive and the dorsal lamella of the principal olive 
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[9, 26].  Our conclusion that the timing of CR abolition depends on the rate of drug diffusion 
to the facial representation in the IO is consistent with the distribution of our injection sites 
(Fig. 1).  Animals having the fastest onsets of behavioral effects were those injected closest 
to the rostro-medial parts of the dorsal accessory IO (Fig. 1, sections D and E).  On the other 
hand, rabbits that were injected in the most rostral locations (Fig. 1 A, B) displayed the most 
delayed effects and required higher volumes of muscimol to achieve complete CR block.  An 
important contribution of the present study is its use of synaptically acting drugs to exclude 
any possible participation of fibers of passage in the observed behavioral effects.  Could it 
be, though, that both muscimol and DGG spread to some other extra-olivary, CR-related 
neurons?  This seems unlikely.  The closest relevant structures in this area are the facial and 
spinal trigeminal nuclei [12].  Involvement of these nuclei does not fit the pattern of 
measured effects.  First, their inactivation should affect predominantly the ipsilateral eye 
[15,11,8].  Yet, CRs were abolished on the contralateral side.  A second argument against a 
confounding spread to the facial and trigeminal areas is that the shortest distances from 
injection sites to these targets are from the most rostral for the facial nucleus, and from the 
most lateral and dorsal for the trigeminal nucleus.  As indicated above, the most rostral 
injections were the least effective in affecting CRs.  This, together with preserved 
unconditioned responses, is inconsistent with significant involvement of the facial nucleus.  
Also, injection sites closest to the spinal trigeminal nucleus and medullary eyeblink 
premotoneurons [12] would be locations dorsal to our present injection sites.  However, 
injections placed more dorsal during the functional mapping phase of the experiment had 
little or no effect on CRs, indicating that if drug spread to the spinal trigeminal nucleus 
and/or medullary eyeblink premotoneurons, it was not primarily responsible for CR 
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suppression.  Since there is no other potentially confounding target in the area, we conclude 
that CR abolition was most likely due to suppressing of activity in the rostral parts of the 
dorsal accessory and principal IO.   
2.5.2 The mechanisms for IO inactivation effects   
Electrophysiological results of the present study offer an important insight into the 
possible mechanism of IO inactivation-induced CR abolition.  Early studies demonstrated 
that permanent lesioning or reversible inactivation of the IO has profound effects on tonic 
activity of the cerebellum.  Specifically, removing the IO input to the cerebellum 
dramatically increased the simple spike frequency of inhibitory Purkinje cells [22], whose 
increased activity suppressed the activity of deep cerebellar nuclei [3].  Interestingly, reduced 
activity in the cerebellar nuclei also suppresses the activity in one of their main targets, the 
red nucleus [5].  These data suggested that blocking the IO could produce a wave of tonic 
changes altering the functional state of the cerebellum and propagating to cerebellar efferent 
targets.  Our neuronal recording data show for the first time that a similar process occurs in 
the rabbit eyeblink conditioning preparation.  The sequence of related events is illustrated in 
Fig. 8.  We discovered that blocking fast glutamate neurotransmission in the IO dramatically 
reduces neuronal activity in the cerebellar IN.  Inactivating the IO produced behavioral 
effects and changes in neuronal activity that were strikingly similar to those produced by a 
direct inactivation of the IN [1].  Since the normal activity of IN neurons is required for CR 
expression, the suppression of IN activity seems to be causing the IO inactivation-induced 
CR abolition.  Consistent with this notion, the decline of IN activity in the present 
experiment slightly preceded CR abolition.    
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Fig. 8.  Schematic of circuits affected by the IO inactivation and of the related 
cascade of changes of tonic activity.  A – Simplified schematic of the intermediate 
cerebellum-related parts of eyeblink conditioning circuits.  Boxes represent involved 
structures and arrows represent axonal connections.  Connections labeled Glu are excitatory 
and mediated by glutamate.  Connections labeled GABA are inhibitory and GABA mediated.  
In the present experiment, inferior olive (IO) was inactivated by blocking fast glutamate 
receptors or by activating GABA-A receptors.  Recordings of the accompanying changes of 
single-unit activity were performed in interposed nuclei (IN).  CS – conditioned stimulus 
input; US – unconditioned stimulus input; PN – pontine nuclei; CC – cerebellar cortex; EPN 
– eyeblink pre-motoneurons. B – Idealized schematic of the IO inactivation-induced tonic 
changes that suppressed the cerebellar output and abolished CRs.  Injections of DGG in the 
IO suppressed the firing rate of IO neurons (IOFR).  This decreased the incidence of complex 
spikes in Purkinje cells of the cerebellar cortex (PC:CS).  We speculate that this produced a 
dramatic increase of Purkinje cell’s simple spike firing rate (PC:SS).  The increased firing of 
GABA-releasing Purkinje cells then inhibited the activity of IN neurons (INFR), which 
resulted in the decrease of the drive to eyeblink pre-motoneurons and CR abolition.  FR – 
firing rate. 
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The present results are pertinent to ongoing interest in the concept that the IO 
provides the cerebellum with trigeminal US signals that reinforce cerebellar learning.  The 
concept suggests that blocking the trigeminal input to the IO should induce CR extinction 
[21].  Since blocking AMPA receptors in the IO eliminates the IO response to facial 
stimulation [17], our DGG injections most likely blocked this IO US input.  We found, 
however, that injecting the IO with DGG rendered the cerebellum dysfunctional, making it 
impossible to observe effects postulated by cerebellar learning.  Could it be that a more 
selective block of specific receptor types, such as AMPA receptors, could suppress sensory 
inputs to the IO without modifying tonic cerebellar activity?  Although one study seems to 
support this possibility [21], we were not able to replicate it [24].  Nevertheless, the IO 
inactivation-induced tonic shift in cerebellar tonic activity does not exclude participation of 
the IO in learning.  It is possible that the IO performs both the tonic-regulatory and error-
signaling functions.  One of the main conclusions of the present study is that because of 
associated tonic effects, IO inactivation methods are ill-suited for testing the functional 
significance of IO sensory signals. 
Even though we did not record IN activity during muscimol injections, data from 
reduced preparations indicate that tonic GABA-ergic inhibition of the IO reduces its activity 
[18], which is known to strongly elevate Purkinje cell activity [4].  Since increased Purkinje 
cell activity would be expected to suppress the firing of IN neurons, it is likely that direct 
muscimol injections in the IO abolish CRs via these same cerebellar mechanisms.   
In summary, the present data suggest that the IO has a powerful influence on tonic 
activity in the intermediate cerebellum and that CR abolition following IO inactivation by 
DGG or muscimol is a consequence of suppressing neuronal activity in the IN.  This 
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conclusion confirms earlier speculations [28,30], and it offers a feasible mechanism to 
explain results of prior attempts to block the IO input to the cerebellum.  An intriguing 
question is whether tonic phenomena triggered by IO inactivation take place in normal 
physiological states.  Since the IO receives inhibitory inputs from cerebellar and extra-
cerebellar sources [10], it is plausible that tonic inhibition of the IO could be important for 
setting tonic functional states of the cerebellum, or for gating the cerebellar output flow in 
normal animals.  It should be emphasized that tonic phenomena associated with changes in 
IO activity do not preclude other functions, such as providing the cerebellum with error or 
reinforcing signals [13,25].  However, testing these concepts will require new techniques for 
blocking sensory inputs to the IO without altering cerebellar tonic activity.   
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CHAPTER 3.  CEREBELLAR DYSFUNCTION EXPLAINS THE 
EXTINCTION-LIKE ABOLITION OF CONDITIONED EYEBLINKS 
FOLLOWING NBQX INJECTIONS IN THE INFERIOR OLIVE   
A paper is accepted by The Journal of Neuroscience 
S. Zbarska1,2, J.R. Bloedel and V. Bracha3 
3.1 Abstract 
Classical conditioning of the eyeblink response is a form of motor learning that is 
controlled by the intermediate cerebellum and related brainstem structures.  The inferior 
olive (IO) is commonly thought to provide the cerebellum with a “teaching” unconditioned 
stimulus (US) signal required for cerebellar learning.  Testing this concept has been difficult 
because the IO, besides its putative learning function, also controls tonic activity in the 
cerebellum.  Recently it was reported that inactivation of AMPA/kainate receptors in the IO 
produces extinction of conditioned responses (CRs), suggesting that it blocks the 
transmission of US signals without perturbing the functional state of the cerebellum.  
However, the electrophysiological support for this critical finding was lacking, mostly 
because of methodological difficulties in maintaining stable recordings from the same set of 
single units throughout long drug injection sessions in awake rabbits.  To address this critical 
issue, we used our microwire-based multiple single-unit recording method.  The IO in trained 
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rabbits was injected with the AMPA/kainate receptor blocker, NBQX, and its effects on CR 
expression and neuronal activity in the cerebellar interposed nuclei (IN) were examined.  We 
found that NBQX abolished CR expression and that delayed drug effects were independent 
of the presentation of the conditioned stimulus (CS) and were therefore not related to 
extinction.  In parallel to these behavioral effects, the spontaneous neuronal activity and CR-
related neuronal responses in the IN were suppressed, suggesting cerebellar dysfunction.  
These findings indicate that testing the IO’s role in learning requires methods that do not 
alter the functional state of the cerebellum.    
3.2 Introduction 
Classical conditioning of the eyeblink response is a form of motor learning that 
critically depends on the intermediate cerebellum.  Lesioning or inactivation of the 
interposed nuclei (IN, the output of the intermediate cerebellum) prevents acquisition of new 
conditioned responses (CRs) as well as the expression of previously acquired CRs 
(McCormick and Thompson, 1984; Yeo et al., 1985; Welsh and Harvey, 1989; Bracha et al., 
1994; Krupa and Thompson, 1997).  A popular explanation for the CR’s cerebellar 
dependency is the cerebellar learning hypothesis.  According to this concept, the intermediate 
cerebellar cortex, and to a lesser degree the IN, receive information about the conditioned 
stimulus (CS) via mossy fibers and about the unconditioned stimulus (US) via climbing 
fibers.  It has been postulated that during learning the interactions between mossy and 
climbing fiber inputs at points of their convergence induce plastic changes that make the 
cerebellum more responsive to mossy fiber CS input.  The enhanced responses to the CS are 
thought to generate CRs (Marr, 1969; Thompson, 1986). 
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The inferior olive (IO), which is the exclusive source of cerebellar climbing fibers, is 
a pivotal structure within the cerebellar learning hypothesis framework.  Based on this 
proposal, the IO provides the cerebellum with a “teaching” US signal.  If so, blocking the IO 
input to the cerebellum should prevent CR acquisition and it should also extinguish 
previously learned CRs (McCormick et al., 1985; Mintz et al., 1994).  Confirming these 
predictions experimentally has been difficult because blocking the IO input to the cerebellum 
produces incapacitating shifts in tonic activity within eyeblink circuits.  Inactivating the IO 
increases the firing rate of cerebellar Purkinje cells, which in turn inhibit cerebellar output 
nuclei (Montarolo et al., 1982; Benedetti et al., 1983; Batini et al., 1985).  This physiological 
mechanism interferes with testing the learning-related function of the IO.  For example, when 
examining whether IO inactivation extinguishes CRs, we provided evidence that the GABA-
A agonist, muscimol, and the broad-spectrum glutamate receptor antagonist, DGG, each 
abolished CRs not because of extinction, but simply due to tonic dysfunction of cerebellar 
circuitry (Zbarska et al., 2007).  However, in a separate study, Medina et al. (2002) reported 
the intriguing finding that injecting the AMPA/kainate receptor antagonist, NBQX, in the IO 
suppressed CRs in an extinction-like fashion.  Did injecting the IO with NBQX affect US 
signals selectively while preserving normal tonic activity of the cerebellum?  This is a pivotal 
question since an affirmative answer would strongly support an IO “teaching” function.  To 
address this issue, we used an advanced method of long-term single-unit recording in pre-
trained rabbits while we microinjected NBQX in the IO in order to assess simultaneously the 
effects of this manipulation on CR expression and the responses and tonic activity of IN 
neurons.  Here we report that blocking AMPA receptors in the IO abolishes CRs by 
suppressing both the tonic and CR-related neuronal activity in the IN and that the delayed 
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(extinction-like) behavioral effects of NBQX most likely stem from the diffusion of injected 
drug. 
3.3 Materials and Methods 
3.3.1 Subjects 
Fifteen male, New Zealand White Rabbits (Harlan, Indianapolis, Indiana), weighing 
2.5-3.0 kg (3-4 months old at the beginning of experiments), were used in these studies.  
Twelve rabbits were included in a study examining the effects of IO inactivation on CR 
expression (IO injection group).  Four animals were used in experiments testing the effects of 
IO inactivation on CRs and on neuronal activity in the IN (IN recording group).  Rabbits 
were housed individually on a 12/12 hr light/dark cycle and provided with food and water ad 
libitum.  All experiments were performed in accordance with the National Institutes of 
Health’s “Principles of Laboratory Animal Care” (publication No. 86-23, revised 1985), the 
American Physiological Society’s “Guiding Principles in the Care and Use of Animals,” and 
the protocol approved by Iowa State University’s Committee on Animal Care. 
3.3.2 Surgery 
Before any training all animals were implanted either with an injection cannula or 
with both an injection cannula and recording hardware using sterile surgical techniques.  
Rabbits were anesthetized with a mixture of ketamine (50 mg/kg), xylazine (6 mg/kg), and 
acepromazine (1.5 mg/kg) and placed in a stereotaxic apparatus with lambda positioned 1.5 
mm below bregma.  After exposing the skull, three stainless steel anchor screws and a 28-
gauge injection guide tube were implanted.  For targeting anterior parts of the right IO, the 
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following stereotaxic coordinates (relative to lambda) were used: AP = x - (0.69x + 4.5) mm 
anterior to lambda (x is horizontal distance between bregma and lambda in mm), ML = 1.0 
mm lateral to lambda, and DV = 22.4 mm ventral to lambda.  The patency of the injection 
guide tube was protected between experiments by a 33-gauge stainless steel stylet.  
The four rabbits in the IN recording group were also implanted with a microelectrode 
array/micromanipulator assembly targeting the left IN as in Aksenov et al. (2004).  The 
manipulator contained three bundles of microwire electrodes totaling 14 electrodes (stainless 
steel, 18 µm diameter, Formvar insulation).  The microwires were connected to a 15-pin 
connector embedded in dental acrylic.  The stereotaxic coordinates for the IN implant were: 
AP = x - (0.69x + 4.8) mm anterior to lambda (x is distance between bregma and lambda in 
mm), ML = 5.0 mm lateral to lambda, and DV = 14 mm ventral to lambda.  The guide tube, 
manipulator, connector, anchor screws, and a small Delrin block designed to accommodate 
an air-puff delivery nozzle and an eyeblink sensor were secured in place with dental acrylic.  
Following surgery, the manipulator and injection guide tube were protected with removable 
Delrin caps.  All animals were treated with antibiotics during a 5-day post-surgical recovery 
period.   
3.3.3 Training procedures 
One week post-surgery, all rabbits were first adapted to a restraint box in a sound-
attenuated experiment chamber for 3 days, 30 min per day.  Head movements were not 
restricted either during adaptation or during experiments.  Adapted animals were conditioned 
in the standard delay classical conditioning paradigm until they reached 90% of conditioned 
responses (CRs) for at least two consecutive days.  The conditioned stimulus (CS) was a 
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binaural 450-ms, 80-dB SPL, 1-kHz tone, superimposed on a 70-dB white noise.  As the 
unconditioned stimulus (US), a 100-ms, 50-psi (at the source) air puff was applied to the left 
eye.  The inter-stimulus interval was 350 ms.  The inter-trial interval varied pseudo-randomly 
from 15 to 25 s.  Rabbits had one conditioning session of 100 paired trials per day until they 
reached 90% of CRs for two consecutive days.   
3.3.4 Injection procedures 
Before each injection experiment a 33-gauge stainless steel needle was inserted in the 
intracranial guide tube.  The injection needle was connected to a 10-µl Hamilton syringe 
using transparent Tygon tubing.  The pressure microinjections were performed manually at a 
rate of 0.5 µl/min.  The injected volume was monitored by observing the movement of a 
small air bubble relative to gradation marks on the transparent tubing.  During injection 
sessions, 40 trials of paired stimuli were applied prior to the injection to assure that needle 
insertion had no effect on CR performance.  Injections were not administered if rabbits had 
less than 85% CRs during the pre-injection baseline period.  NBQX (Sigma-Aldrich) was 
dissolved in artificial cerebrospinal fluid (aCSF, Medina et al., 2002) and its pH was adjusted 
to 7.4±0.1. 
Functional mapping and non-waiting experiment.  To increase the yield of 
experiments, we first determined the effective vertical placement of NBQX injections by 
gradually increasing the injection depth.  During the first mapping session, NBQX (0.5 µl, 
150 µM) was injected at the depth of the guide tube tip.  Mapping sessions consisted of 40 
pre-injection trials and 160 post-injection trials, which were administered immediately 
following the initial NBQX injection.  Similar to Medina et al. (2002), additional 0.5 µl 
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injections were administered at 5 min intervals until an effect of the drug on CRs was 
observed or until a total of eight injections was reached; the total volume of NBQX ranged 
from 0.5 to 4 µl among rabbits.  If no effect on CR incidence was observed, the depth of 
injection was adjusted, progressing 0.5 mm deeper the next day.  This daily increase of 
injection depth was repeated until NBQX completely abolished CRs, or until the needle 
reached the base of the skull.  The last functional mapping session was included in the data 
analysis as the non-waiting experiment.   
The waiting experiment.  The next day following the non-waiting test, all rabbits were 
tested in a waiting experiment, consisting of three parts.  In the first part, 40 trials were 
delivered to assess normal pre-injection CR performance. The second part was a waiting 
period designed to allow for effective drug diffusion before CS-US stimulation was resumed.  
During this period the same amount of NBQX was administered using the same injection 
schedule as in the previous non-waiting experiment.  No stimuli were presented during the 
waiting period and its duration was set to last 5 min longer than the time it took to abolish 
CRs in the non-waiting experiment in each particular animal.  Following the waiting period, 
CR performance was tested in 160 trials.   
Controls.  During control experiments, a corresponding volume of vehicle (aCSF) 
was administered into the IO using the same injection and paired stimulation schedule as in 
NBQX experiments. 
Injections in the IN recording group.  The four rabbits in the IN recording group were 
repeatedly tested both in waiting and non-waiting experiments using NBQX and aCSF 
injections.  To capture the behavioral and neuronal recovery, we extended the post-injection 
observation period to a maximum of 260 trials.  If the behavioral CR recovery occurred and 
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was maintained for 40 trials (waiting experiment) or 30 trials (non-waiting experiment), the 
recording session was terminated before 260 post-injection trials were completed.  Once the 
effect of NBQX had been tested on a group of isolated single units, the microwire electrodes 
were advanced deeper to find an additional group of IN neurons.  If new neurons were 
isolated, then another set of NBQX and aCSF experiments were repeated on these new units.  
This procedure was repeated until no more new units could be isolated, or until the NBQX 
injections became ineffective due to gliotic scarring around the IO injection site.  Not all IN 
units were paired with control injections of aCSF because of the need to limit the number of 
needle insertions at the injection site, and because some units degraded or were lost before 
they were ready to be tested against aCSF. 
3.3.5 Data recording and analysis 
In the IO injection group, the eyeblink was recorded using a new, wide field-of-view 
infrared sensor (Ryan et al., 2006), which was attached to the rabbit’s head implant before 
each experiment.  This arrangement secured the constant position of the sensor relative to the 
eye, yielding reliable eyeblink recordings without the need for head restraint.  The sensor’s 
signal was amplified, digitized at 1 kHz with 12-bit resolution, and displayed and stored on a 
custom data acquisition system.  Data were acquired for 1400 ms in each trial, starting 250 
ms before the CS onset.  Eyeblink responses beginning between 80 ms after CS onset and up 
to the US onset were considered CRs when they exceeded the mean of the signal in the 250-
ms baseline period by more than five standard deviations (approximately 0.1 mm).  This 
relatively low threshold was selected to capture small responses that could be present during 
an incomplete drug effect or when the drug effect starts to recover.  Spontaneous responses 
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were defined as trials in which the difference between the maximum and minimum values in 
the baseline period exceeded 0.5 mm.  Any blink exceeding the CR threshold within 80 ms 
after CS onset was recognized as an alpha response.  Trials containing spontaneous blinks or 
rare alpha responses were stored but were not included in further data analyses.  
Measurements of eyeblink responses were used for calculations of CR incidence per block of 
10 trials in each session.   
In addition to the visualization of eyeblink traces on the computer monitor, two video 
cameras were installed in the experiment chamber to monitor general animal behavior during 
experiments.  One camera provided a front view of the rabbit’s head and the other one, 
configured for infrared viewing, was positioned on the side of the trained eye.  This setup 
proved to be invaluable for monitoring rabbit behavior continuously.   
In the IN recording group, multiple single-unit signals from microwire electrodes 
were fed through a custom miniature 14-channel FET-based preamplifier to a multi-channel 
differential amplifier system (Grass-Telefactor model 12 Neurodata System).  The amplified 
and band pass-filtered (300 Hz-3 kHz) signal was digitized (25 kHz/channel) using a custom 
data acquisition system, and was displayed and stored in 1400-ms epochs corresponding to 
individual trials.  Unit discrimination was performed offline using threshold detection 
followed by a cluster analysis of scatter plots of time and amplitude distances between the 
peak and valley of individual action potential waveforms.  The discriminated data were 
processed using custom software in addition to a commercial data analysis package 
(NeuroExplorer, Nex Technologies).  Cross-correlation analysis was performed for each unit 
to eliminate multiple inclusions of the same unit recorded on different wires within a bundle.  
Raster and peri-event histograms were constructed for each unit.  For cells recorded during 
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the waiting period test, separate histograms were constructed for 30 pre-injection trials, 30 
trials during the waiting period while injecting, 30 trials for the post-injection period when 
stimulation was resumed, and 30 trials at the end of session representing recovery.  The 
criterion for identifying the recovery period was the complete behavioral reappearance of 
CRs by the end of the experiment or the last 30/40 trials of a 260-trial experiment.  In the 
latter case the behavioral recovery could be incomplete.  In each histogram, the baseline 
firing rate (250 ms before CS onset) and the timing of significant excitatory and inhibitory 
changes were computed.  Cell responses were considered significant if modulation of the 
firing rate from the CS onset until the end of the trial exceeded the mean baseline ± tolerance 
limit for two consecutive 20-ms bins.  Tolerance limits were computed to capture 95% of the 
baseline distribution with a probability of 0.95.  
Baseline means of individual cell histograms were pooled together within NBQX, 
NBQX waiting and control experiments and then statistically analyzed.  Only units that were 
isolated reliably throughout an experiment, as judged by the invariance of the shape and size 
of action potentials, were included in the data analysis.   
For the statistical analysis, we used repeated measures ANOVA with the following 
factors: drug (3 levels: drug, drug with delay, and aCSF) and time/dose (4 levels: before 
injection, injection-no stimulation, after injection- stimulation resumed, and recovery).  The 
repeated factor was the four 10-trial blocks for non-waiting experiments and three 10-trial 
blocks for waiting experiments comprising each phase of an experiment.  For the analysis of 
IN group cell activity, the ANOVA included an additional blocking factor (rabbit) to account 
for multiple cells recorded from the same animal.  We generated planned contrasts from the 
ANOVAs to address a priori hypotheses regarding patterns of CR incidence and baseline 
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activity of IN neurons arising from the interaction between treatments and phases of an 
experiment.  Specifically, using groups of 10-trial blocks, we performed 1-df contrasts 
between pre-injection, waiting, post-waiting and recovery within and between experiments 
with no time delay, with time delay, and their controls.  All group data are reported as mean 
± standard error of the mean.  The level of statistical significance was set at p<0.05.  All 
statistical analyses were performed using Statsoft Statistica software. 
3.3.6 Histology 
After all experiments were completed, rabbits were deeply anesthetized with a 
mixture of ketamine (100 mg/kg), xylazine (12 mg/kg), and acepromazine (3 mg/kg).  The 
injection site was marked by injecting 1 µl of tissue-marking dye.  Anesthetized animals 
were transcardially perfused with 1 L of phosphate-buffered saline followed by 1 L of 
fixative (10% buffered formalin) and 1 L 10% potassium ferrocyanide in 10% formalin.  The 
potassium ferrocyanide was applied only to IN-recording rabbits, where the location of 
electrodes was marked by passing 10 µA anodal DC current through each wire for 20 s.  
Brains were removed and placed in a solution of 30% sucrose and 10% formalin.  After one 
week, brains were sectioned coronally at 50 µm on a freezing microtome.  Sections were 
mounted onto gelatin-coated slides, dried, and stained with either Luxol blue and neutral red 
(IO injection group) or with ferrocyanide hydrochloride and neutral red (IN recording group).  
Locations of injection sites were determined using bright field microscopy and transferred to 
a standardized set of coronal sections of the rabbit medulla.  Locations of electrode marks 
were transferred to a standardized set of coronal sections of the rabbit cerebellar nuclear 
region. 
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3.4 Results 
3.4.1 Location of injection sites and general observations  
A total of 15 rabbits were implanted with an injection cannula in the IO.  Three 
animals were not included in the data analysis because low-concentrations of NBQX 
(150µM) injected in the IO did not affect CR expression.  Of the remaining 12 rabbits, four 
also had recording electrodes implanted in the IN.  The histological reconstruction of IO 
injection sites revealed that they were located in the rostral portion of the inferior olivary 
complex, close to the rostral part of the dorsal accessory inferior olive (Fig.1).   
All rabbits reached the 2-day 90% CR criterion in 5 to 12 sessions.  The mean CR 
incidence was 91.4±0.5% in the final training session.  Once effective injection sites were 
established through functional mapping, microinjections of NBQX reliably abolished CRs, 
albeit with a variable delay (see sections 3.2 and 3.3 for additional information).  Unlike 
DGG and muscimol, which in our previous study increased tonic eyelid aperture and affected 
eye movement and body posture (Zbarska et al., 2007), NBQX injected to the IO did not 
have any visible side effects. 
3.4.1 Effect of NBQX on CR expression 
Immediate post-injection test in the non-waiting experiment.  Injecting NBQX at 
effective injection sites abolished CR expression.  Typically, rabbits exhibited high CR 
incidence during pre-injection trials, followed by gradual CR suppression in the post-NBQX 
infusion period (Fig. 2A).  During the individual experiment shown in Fig. 2A, 3.0 µl of  
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Fig. 1.  Location of injection sites in the IO injection group (●, n=8) and in the IN 
recording group (  , n=4).  The identified sites in individual animals were transferred to a set 
of standardized coronal sections of the rabbit medulla, arranged in rostral-to-caudal order (A-
H).  The anterior-posterior distance in mm from the rostral pole of the IO is on the lower 
right side of each section.  All injection sites were found within or close to the rostral part of 
the inferior olivary complex.  Injections of NBQX at all marked sites abolished CR 
expression.  DAO - dorsal accessory inferior olive; IOM - medial inferior olive; IOPr - principal 
inferior olive; IOA - subnucleus A of the medial inferior olive; IOB - subnucleus B of the medial 
inferior olive; IOK - cap of Kooy of the medial inferior olive; Sp5N - spinal trigeminal nucleus; 
sp5 - spinal trigeminal tract; Pr - prepositus hypoglossal nucleus; 7N - facial nucleus; icp - 
inferior cerebellar peduncle; MVe - medial vestibular nucleus; SolN - solitary nucleus; Amb - 
ambiguous nucleus; 12n - hypoglossal nerve; 10N - dorsal motor nucleus of the vagus; DCN 
- dorsal cochlear nucleus.   
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NBQX were delivered in six 0.5-µl increments spaced 5 minutes apart.  CRs were gradually 
abolished over the course of about 23 minutes since first injecting NBQX and they did not 
recover during the rest of the experiment.  Injections of the same volume of vehicle at the 
same site had no effect on CR incidence (Fig. 2C).   
The onset timing of CR abolition among rabbits varied from immediate to 
approximately 35 min post-injection.  Group data (n=12) revealed that CR incidence 
gradually decreased from 90.0±4.3% in the last pre-injection block of 10 trials to 5.0±2.3% 
in the seventh post-injection block (Fig.3).  Complete or partial recovery of CRs by the end 
of the experiment was observed in six out of twelve rabbits; during the last 10-trial block, 
mean CR incidence was 31.0±10.1% (Fig.3).  This decline of CR incidence contrasted with 
stable CR performance in control experiments before (93±2.7%) and after (90.3±3.9%) 
vehicle injections.  The repeated measures ANOVA yielded significant drug effects.  Planned 
comparisons revealed a significant effect of NBQX (F1,30=254.2, p<0.001) when contrasting 
overall pre- and post-injection CR performances, whereas effects of vehicle were 
insignificant (F1,30=0.3, p=0.570).     
The effect of lower concentrations of NBQX was tested on one rabbit, which in the 
non-waiting experiment showed almost immediate abolition of CRs after the first of two 
0.5µl injections of NBQX (150µM, Fig. 4A).  In this animal, even an NBQX concentration 
eight-times lower (19µM) quickly abolished CRs with an effect lasting about 50 trials before 
CRs recovered (Fig. 4B).  Also, CR abolition does not always require repeated injections of 
NBQX.  We observed CR abolition after a single NBQX injection in one rabbit and after two 
injections in two rabbits. 
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Fig. 2.  Individual examples from the same subject showing behavioral effects of 
microinjecting NBQX and vehicle (aCSF) into the IO.  Each stack plot represents a complete 
printout of eyeblinks from a 200-trial injection experiment.  The experiments start at the top, 
and each eyeblink trace represents one trial.  The timing of injections is denoted by an arrow 
in each stack plot.  Conditioned eyeblinks are upward deflections of the signal between the 
vertical CS and US onset markers.  A: Eyeblinks in an experiment where CR testing was 
resumed immediately following the injection of NBQX.  Note that CRs were gradually 
abolished 23 minutes after NBQX.  B: Stack plot of eyeblink mechanograms from an 
experiment in which the rabbit was injected with the same amount of drug, but the CR testing 
was delayed by inserting a waiting period for NBQX diffusion.  In this test, CRs were absent 
immediately after stimuli resumed, indicating that the delayed drug effect in part A was 
simply a function of time, most likely related to drug diffusion.  Note the partial recovery of 
CRs as the waiting experiment continued an extra 25 min.  C: Eyeblinks in the control 
experiment in which injections of the same amount of vehicle (aCSF) did not affect CRs. 
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The waiting period test.  The waiting period test was administered to examine 
whether the gradual NBQX-induced abolition in the previous test was related to CR 
extinction or to some other time-dependent process, such as drug diffusion.  If the gradual  
CR abolition represented CR extinction, then we expected that postponing the CS-US 
presentation following the NBQX injection should have no effect on the time course of CR 
suppression.  This prediction was not confirmed.  Figs. 2B and 4C illustrate that CRs were 
absent immediately from the beginning of the post-injection test.  Clearly, the NBQX-
induced CR suppression did not require the presentation of the CS, which is necessary for CR 
extinction.  In most waiting experiments, CRs partially recovered by the end of post-injection 
testing (Fig. 2B, 4C). 
During the waiting period test, mean CR incidence precipitously declined from 
96.5±2.6% in the last block of pre-injection trials to 5.0±1.5% during the first 10 post-
waiting trials (Fig. 3).  The post-waiting decline in CR incidence was significant both when 
compared to the pre-injection period (F1,30=307.7, p<0.001) and to the first block of 40 post-
injection trials in the non-waiting test (F1,30=36.8, p<0.001).  Because of the extended period 
of observation during waiting period tests, CRs tended to recover in these experiments, 
starting from the fifth post-waiting block of trials.  This recovery was observed in eight out 
of twelve rabbits with one of them illustrated in Fig. 2B.  In the last 10-trial block after the 
waiting period test, mean CR incidence in the IO injection group was 55.8±12.2%.  During 
the last 40 trials after the waiting period test, CR incidence had partially recovered to 
49.2±11.8%, which was significantly different from the corresponding block of trials in the 
non-waiting test (20.3±9.0 %, F1,30=6.0, p=0.02).   
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Fig. 3.  Effects of NBQX on CR incidence (±SE) in IO injection rabbits (n=12) when 
tested immediately following the injection (▲)  and following the diffusion waiting period 
(□) are compared to those observed following the control injection of vehicle (○).  The 
vertical dashed line denotes the onset of NBQX injections.  Note that up to 6 blocks of trials 
were required to obtain complete CR abolition in the non-waiting test, while CRs were 
immediately absent in the first post-injection block of the waiting test.  Injection of vehicle 
(aCSF) did not affect CR incidence.   
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Fig. 4.  Stack plots of all eyeblinks recorded in three separate experiments from the 
same animal showing the behavioral effects of microinjecting different concentrations of 
NBQX in the IO.   A: An experiment where CRs were tested immediately following an 
injection of 1.0 µl of NBQX (150 µM).  CRs were almost immediately abolished after 1 min 
of post-injection training.  B: Eyeblinks in an experiment where 1.0 µl of 8-times less 
concentrated NBQX (19 µM) was injected and then an immediate test was performed.  CRs 
were abolished following several post-injection trials, but the duration of the effect was 
shorter than that obtained with the higher concentration of NBQX shown in A.  C: Eyeblinks 
in an experiment where post-injection testing of 19 µM NBQX was delayed by a 5 min 
diffusion waiting period.  Note that CRs were absent starting from the first post-injection 
trial, and then 10 minutes later they started to recover.  For additional plot information, see 
Fig. 2. 
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3.4.2 Effect of NBQX injection in the IO on neuronal activity in the IN 
Immediate post-injection test.  The histological reconstruction performed in the four 
IN recording rabbits revealed injection sites located close to the rostral portion of the dorsal 
accessory olive (Fig. 1).  All recording sites were located in the IN, with the majority of 
electrodes in the anterior IN (Fig. 5).  In total, 27 neurons were recorded during NBQX 
injections and 20 neurons during injections of vehicle, all in the non-waiting experiment.  
Single-unit recordings revealed that the gradual CR abolition induced by NBQX coincided 
with the gradual suppression of spontaneous firing rates of IN cells (Figs. 6 A, B). 
  
Fig. 5.  Reconstruction of cell recording sites in the IN.  Out of 12 electrode bundles 
in four rabbits, eight were located in the anterior IN and four at the caudal border of the InA 
between the DN and InP.  Their position was transferred to a set of standardized coronal 
sections of the rabbit cerebellar nuclear region.  Sections are arranged in rostral-to-caudal 
order (A-D).  InA - anterior interposed nucleus; DN - dentate nucleus; LV - lateral vestibular 
nucleus; SV - superior vestibular nucleus; InP - posterior interposed nucleus; FN - fastigial 
nucleus; scp - superior cerebellar peduncle; icp - inferior cerebellar peduncle. 
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Fig. 6.  Group effects of NBQX on CR performance and on IN activity during the 
non-waiting test.  The last four blocks of trials represent the recovery period and are 
separated from the rest of the plot by a gap.  A: Effects of NBQX on mean baseline activity 
(±SE) of IN cells (n=27).  The firing rate of IN cells gradually decreased within the first four 
blocks of trials after the injection of NBQX (▲), and it remained at slightly above 10Hz for 
the next 60 trials. The spontaneous activity almost completely recovered during the last four 
blocks of the experiment.  Injections of aCSF (○) had no effect on IN firing rate (n=20).  B: 
Effects of NBQX (▲) on mean CR incidence (±SE; n=7) in the same set of experiments as 
depicted in A.  CRs were gradually abolished and then partially recovered by the end of 
testing.  This behavioral effect parallels changes in IN activity shown in A.  Control 
injections of vehicle did not affect CR performance. 
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In this NBQX cell population, the mean baseline firing rate decreased significantly, 
first from 29.8±2.3 Hz pre-injection to 19.2±3.0 Hz by the third post-injection block of 10 
trials, and then to 11.0±2.5 Hz by the fifth post-injection block (Fig. 6 A, Blocks 1-4 vs. 5-
14, F1,42=70.2 , p<0.001).  The baseline firing rate markedly recovered during the last 40 
trials (Blocks 5-14 vs. 15-18, F1,42= 51.8, p<0.001), and it almost reached its pre-injection 
level of activity (Blocks 1-4 vs. 15-18, F1,42=6.0 , p=0.018).  In contrast, the mean firing rate 
during control experiments remained stable after vehicle-only injections (Fig. 6A, Blocks 1-4 
vs. 5-14, F1,42=0.030, p=0.864).  The time gap between the last 10-trial block of post-
injection trials (Fig. 6, Block 14) and the first block of the recovery period varied from 7-27 
minutes (20-80 trials). 
The NBQX-induced decrease of IN neuronal activity coincided with a gradual decline 
in mean CR incidence from 93.6±3.9% pre-injection to 34.3±13.8% by the third post-
injection block, and then to 4.29±3.0% by the eleventh block (Fig.6B, Blocks 1-4 vs. 5-14, 
F1,8=495.3, p<0.001).  Likewise, a behavioral recovery, which paralleled the recovery of 
neuronal activity during the last 40 trials, was significant when compared to blocks 11-14 
(F1,8=245.6, p<0.001), but it was incomplete relative to the pre-injection level (F1,8=40.0, 
p<0.001).  Control injections of aCSF in the IO had no effect on CR incidence which was 
95.0±2.6% and 92.3±3.8% before and after vehicle injections correspondingly (Fig.6B). 
The waiting period test.  Inserting a waiting period between the NBQX injection and 
behavioral testing provided a unique opportunity to measure IN activity at this time.  As 
illustrated in an individual example, IN neurons exhibited a strong excitatory response to the 
CS prior to the onset of the US and a combination of excitatory and inhibitory responses to 
the US (Fig. 7A, B).  The NBQX injection in the IO of this rabbit almost immediately  
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Fig. 7.  An example from a waiting period test of the parallel effects of NBQX on CR 
performance and on the activity of a task-modulated IN cell.  This experiment consisted of 
260 trials with the two 0.5 µl NBQX injections administered during 40 trials no-stimulation 
period that began immediately after 40 pre-injection trials.  A: Raster plot of IN cell activity 
during the same experiment.  The experiment starts at the top with each row representing one 
trial, and each dot marking the occurrence of an action potential.  The black square on each 
row corresponds to the onset of the eyeblink in that particular trial.  The 40 black squares at 
the end of rows correspond to the no-stimulation waiting period.   This cell responded with 
excitation during the CS-US interval followed by a combined excitatory/inhibitory response 
to the US.  Shortly after the first NBQX injection, the firing rate of this cell’s activity 
precipitously declined.  When stimulation was resumed, CRs were abolished immediately, 
baseline activity remained suppressed, and modulation during the CS-US interval was 
severely reduced while the relative excitatory modulation to the US became more distinct. 
The neuronal activity gradually recovered toward the end of the experiment in parallel with 
the recovery of behavioral CRs.  B-E: Peri-stimulus histograms of the same IN unit 
constructed for 40 trials before the injection (B), for 40 post-injection waiting trials when 
stimulation was paused (C), for 40 post-waiting period trials when stimulation was resumed 
(D), and for the last 40 trials of the experiment (E).  Bin width for histograms in B-E is 20 
ms. CS, onset of conditioned stimulus; US, onset of unconditioned stimulus. 
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severely suppressed the firing rate of the IN unit during the no-stimulation period (Figs. 7A, 
C).  When stimulation was resumed, behavioral CRs were absent.  At the same time, the 
firing rate of this cell remained inhibited and its modulation was altered.  The excitatory 
response to the CS dramatically decreased and the excitatory response to the US became 
more prominent, albeit shorter-lasting (Figs. 7A, D).  Toward the end of the session the 
behavioral effect gradually recovered (Fig. 7A), accompanied by a partial recovery of the 
neuronal firing rate and modulation (Fig. 7 A, E).  
In total, 88 neurons were successfully held and recorded during the NBQX waiting 
period test and 32 neurons in vehicle injection controls.  Among the 88 NBQX neurons, 79 
cells exhibited a significant decrease in baseline activity during the waiting period when 
compared to the pre-injection level.  Of the nine remaining neurons in this group, eight did 
not change their activity and one neuron significantly increased its firing rate.  The mean 
baseline firing rate of NBQX neurons (n=88) decreased by more than half from 28.1±1.5 Hz 
pre-injection to 13.1±1.3 Hz by the end of waiting period (Fig. 8 A, Blocks 1-3 vs. 4-6, 
F1,118=77.0, p<0.001).  When stimulation was resumed, the mean baseline firing rate 
decreased further to 11.4±1.3 Hz (Blocks 1-3 vs. 7-9, F1,118=104.4, p<0.001).  Recovery of 
the baseline firing rate occurred during the last 30 trials (Blocks 10-12 vs. 4-9, F1,118=66.0, 
p<0.001), but it was incomplete relative to the pre-injection activity (Blocks 1-3 vs. 10-12, 
F1,118=11.3, p=0.001).  The time gap between the last 10-trial block of post-injection trials 
(Fig. 8, Block 9) and the first block of the recovery period varied from 10-43 minutes (30-
130 trials).  The firing rate of IN neurons was not affected by control injections of vehicle, as 
the mean firing rate remained stable before (30.0±2.4%) and after (27.3±2.3%) injections 
(Fig. 8 A, Blocks 1-3 vs. 7-9, F1,118=0.736, p=0.393). 
 86 
 
Fig. 8.  Group effects of 
NBQX on CR 
performance and on IN 
activity during the 
waiting test.  Each 
period of the experiment 
is represented by three 
consecutive blocks of 10 
trials: before injection, 
no-stimulation waiting 
period, post-waiting 
period with stimulation, 
and recovery.  Periods 
are separated by vertical 
dashed lines.  If the 
waiting period was 
longer than 30 trials, 
then the last 30 trials 
before stimulation was 
resumed were included 
in the plot.  A: Effects of NBQX (▲) on mean baseline activity (±SE, n=88) of IN cells.  The 
baseline firing rate of IN cells gradually decreased during the waiting period, it remained low 
when stimulation was resumed and it partially recovered during the last three blocks of the 
experiment.  Injecting aCSF (○) had no significant effect on IN firing rate (n=36).  B: Effects 
of NBQX (▲) on mean CR incidence (±SE; n=32 in the same set of experiments as depicted 
in A.  CRs were completely abolished when stimulation was resumed and then partially 
recovered by the end of testing.  This behavioral effect parallels changes in IN activity shown 
in A.  Control injections of vehicle (○) did not affect CR performance. 
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When stimulation was resumed after the waiting period, CRs were absent at the 
beginning of the post-waiting test (Fig. 8 B).  The mean CR incidence decreased from 
94.3±1.3% in the last block of pre-injection trials to 5.0±1.6% during the first 10 post-
waiting trials (Blocks 1-3 vs. 7-9, F1,43=3165.6, p<0.001).  Similar to the neuronal activity, 
partial recovery of CR incidence was observed in the last 30 trials of the recording session 
(Fig. 8 B), which was significant when compared to post-waiting trials (F1,43=341.4, 
p<0.001), but was incomplete relative to the pre-injection level (F1,43=24.4, p<0.001).  The 
control injections of aCSF did not affect CR incidence (Fig.8 B, Blocks 1-3 vs. 7-9, 
F1,43=3.423, p=0.071). 
To analyze changes in modulation of IN neurons, all cells from NBQX waiting 
experiments (n=88) were subdivided into three subgroups based on their pattern of 
significant modulation in the CS-US interval prior to injections.  Our minimum threshold 
criterion for modulated activity was 2 consecutive 20-ms bins exceeding the upper or lower 
tolerance limits that were calculated from the first 250 ms of pre-injection peri-stimulus 
histograms.  As a result, sixteen neurons exhibited predominantly excitatory modulation, 12 
neurons were largely inhibited and 60 neurons were not modulated.  However, 20 of the 
“non-modulated” cells exhibited a short-latency, short-lasting (20 ms) excitatory response to 
the CS. 
In general, the spontaneous activity of all cell types decreased during the waiting 
period (Figs. 9B, F and J).  When CS-US stimulation was resumed, the modulation of both 
excitatory and inhibitory cells was also reduced, but not completely abolished (Figs. 9C and 
G).  These changes recovered toward the end of the experiment (Figs. 9D, H, and L).  The 
most affected modulation components were the prolonged excitation and inhibition in the  
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Fig. 9.  Effects of NBQX and aCSF injections on cell activity modulation.  Mean 
peri-stimulus histograms are arranged in rows corresponding to cell types and in columns 
representing the activity before injection, during no stimulation waiting period, post-waiting 
period when stimulation was resumed, and recovery.  A–D: cells exhibiting predominantly 
excitatory responses (n=16).  E-H: cells that were inhibited during the CS-US interval 
(n=12).  I-L: non-modulated cells (n=60 ). M–P: cells recorded during control injections of 
vehicle (n=36).  CS, conditioned stimulus onset; US, unconditioned stimulus onset.  Bin 
width is 20 ms.  Horizontal lines in each histogram represent tolerance limits.  For more 
description see section 3.4.  
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CS-US interval (Fig. 9A vs. 9C and 9E vs. 9G).  Interestingly, short-latency excitatory 
responses to the CS and US proved to be relatively resistant to the NBQX effect.  Since the 
IO has been proposed to provide the intermediate cerebellum with the US information, it was 
surprising that relative responses to the US were not dramatically reduced.  Unexpectedly, 
the responses to the US became more prominent in all three cell types (Figs. 9C, G and K).  
In contrast to NBQX experiments, control injections of the vehicle in the IO had no 
significant effects on baseline activity or modulation (Fig.9M-P). 
Since the population super-histograms (Fig. 9) could have means disproportionately 
affected by the depth of modulation of individual cells, we also constructed binary 
histograms.  By depicting cumulative frequencies of significant excitatory and inhibitory 
modulation within each 20-ms bin, this plot (Fig. 10) disregards amplitude of modulation by 
providing information about the percentage of significantly modulated cells.  This analysis 
showed similar results as described above.  Specifically, the incidence of prolonged 
inhibition and excitation in the CS-US interval decreased following the NBQX injection 
(Figs. 10A vs. B).  Interestingly, only inhibitory parts of this response component recovered 
well by the end of the experiment (Figs. 10B vs. C).   Similar to effects seen in Fig. 9, the 
frequency of short-latency responses to the CS was not reduced in the post-injection test.  
Remarkably, injecting NBQX in the IO increased the frequency of both short- and long-
latency excitatory responses to the US (compare Figs. 10A and B) and this effect recovered 
by the end of the experiment (Fig. 10C).  
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Fig. 10.  Frequency histograms of the incidence of significant excitatory (black bars) 
and inhibitory (gray bars) responses in the population of 88 cells recorded during the NBQX 
waiting experiments (A, before injection; B, after injection when stimulation was resumed; C: 
during last 30 trials of experiments).  The fraction of cells exhibiting long-latency excitatory 
or inhibitory responses in the CS-US interval decreased following the NBQX application.  
Also, the incidence of short-latency excitation to the CS remained unchanged and the 
incidence of excitatory responses to the US increased following NBQX.  These effects 
tended to recover toward the end of experiments. 
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3.5 Discussion and Conclusions 
The present study demonstrated that injections of the AMPA/kainate receptor 
antagonist, NBQX, in rostral parts of the inferior olive abolish the expression of eyeblink 
CRs.  This NBQX-induced CR suppression exhibited variably delayed onset timing, ranging 
from an immediate effect to 35 minutes post-injection.  Simultaneous recordings of IN 
single-unit activity revealed that CR abolition was associated with decreased tonic activity 
and changes in evoked neuronal responses in deep cerebellar nuclei.  The waiting test, in 
which CS and US presentations were delayed to permit drug diffusion, showed that these 
effects were simply a function of time and therefore did not require post-injection 
presentations of stimuli. 
3.5.1 Involvement of the IO in expression of CRs – tonic dysfunction vs. 
cerebellar learning hypothesis 
The expression of eyeblink CRs in the rabbit depends critically on the intermediate 
cerebellum.  The IO, which is the exclusive source of cerebellar climbing fibers, is a pivotal 
component of cerebellar eyeblink-related circuits.  A sub-division of the IO, the dorsal 
accessory olive, receives information about peri-ocular stimulation from sensory trigeminal 
nuclei (Walberg, 1982; Gellman et al., 1983; Huerta et al., 1983) and transmits this US signal 
to the intermediate cerebellum.  Previous lesion and inactivation studies (Yeo et al., 1986; 
Welsh and Harvey, 1998) demonstrated that blocking the IO input to the cerebellum 
abolishes CRs immediately following the experimental intervention.  Authors of these 
behavioral studies speculated that a tonic dysfunction of the cerebellar circuit could explain 
this effect.  Specifically, they suggested that CR deficits were caused by a non-specific tonic 
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suppression of activity in cerebellar nuclei that is known to be associated with IO 
lesions/inactivations (Benedetti et al., 1983; Zbarska et al., 2007).  These findings were 
challenged by reports that lesioning (McCormick et al., 1985) or inactivating (Medina et al., 
2002) the IO produces not an immediate, but gradual, extinction-like suppression of CRs.  
These findings were interpreted in terms of the cerebellar learning hypothesis, which 
suggests that the IO input is required for the maintenance of memory traces in the cerebellum 
(Thompson et al., 1998).  According to this concept, blocking the IO gradually weakens 
cerebellar responses to the CS, resulting in CR extinction.  Resolving these conflicting 
inferences from behavioral studies requires measurements of cerebellar neuronal activity 
during IO manipulations.  To address this challenging issue, we applied our method of long-
term single-unit recording to experiments involving IO pharmacological manipulations in 
trained rabbits. 
The behavioral component of the present study clearly supports the tonic dysfunction 
hypothesis.  Blocking the IO’s AMPA/kainate glutamate receptors with NBQX abolished 
CRs either almost immediately, or with a short delay.  This rate of NBQX-induced CR 
suppression was appreciably faster than the rate of normal behavioral extinction previously 
observed in our laboratory (Nilaweera et al., 2005).  In the waiting period test, CRs were 
abolished immediately, starting from the first trial of resumed CS and US presentations.  
These findings are inconsistent with a cerebellar learning hypothesis which postulates that 
NBQX-induced CR “extinction” follows the presentation of paired stimuli and should have a 
rate comparable to normal behavioral extinction (Medina et al., 2002).   
 Since presentation of stimuli was not required to observe CR abolition, we suggest 
that some time-dependent process, such as drug diffusion to relevant parts of the IO complex, 
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explains the delayed cases of the drug effect.  The drug diffusion explanation is consistent 
with the histological reconstruction of our injection sites.  First of all, it is unlikely that CR 
suppression was due to the drug spreading to some other eyeblink-related target outside of 
the IO (Hiraoka and Shimamura, 1977; Holstege, 1990).  Injections of NBQX dorsal to the 
IO made prior to the last mapping experiment had no effect on CRs.  Also, the fastest effects 
were observed in animals with injection sites closest to the rostral-medial pole of the DAO, 
which is known to receive somatosensory information from the contralateral facial region 
(Gellman et al., 1983).  
The tonic dysfunction hypothesis is strongly supported by our recordings of IN 
single-unit activity.  The gradual reduction of CRs is well correlated with a gradual inhibition 
of the spontaneous firing rate of IN neurons in immediate drug tests.  The waiting 
experiments clearly dissociated these processes because the IN firing rate declined during the 
waiting period when rabbits were not stimulated.  When the stimulation resumed, CRs were 
immediately absent on the background of already suppressed IN activity.  This stimulation-
independent and NBQX-induced suppression of IN firing rate is consistent with previous 
reports of the tonic effects of blocking IO input to the cerebellum (Benedetti et al., 1983; 
Bengtsson et al., 2004).  It appears that NBQX down-regulated the IO’s firing rate and this 
up-regulated the activity of Purkinje cells in the cerebellar cortex (Batini et al., 1985; Lang, 
2001; Bengtsson et al., 2004).  The increased activity of these inhibitory cells then 
suppressed activity of IN neurons, as shown by our measurements.  Since sustained 
inhibition of IN neurons suppresses CR expression (Aksenov et al., 2004), we presume that 
the NBQX-triggered tonic shifts in the activity of cerebellar neurons are either partly or 
completely responsible for the observed CR deficit.  Interestingly, even though the NBQX-
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induced suppression of IN activity was sufficient to prevent CR expression, it was smaller 
than what we reported in DGG injection experiments (Zbarska et al., 2007).  Since DGG 
blocks AMPA/kainate and also NMDA receptors, it appears that NMDA receptors participate 
in the regulation of IO firing rates (Placantonakis and Welsh, 2001).  
Although the tonic activity of some IN neurons was completely suppressed, most 
cells continued to fire but at significantly decreased rates.  It is not clear whether the residual 
presence of tonic modulated activity in the IN is related to an incomplete block of 
AMPA/kainate receptors in areas of the IO that project to our recording sites.  Exploring this 
scenario would require injecting excess amounts of NBQX.  We have not yet performed this 
test because interpreting the results of a more complete block could be confounded by excess 
drug spreading to other parts of eyeblink circuits, which would have required additional 
controls.  Similar to changes in spontaneous firing rates, the depth of response modulation 
and its incidence were reduced, but not completely eliminated.  The most reduced response 
components were longer-latency (>60 ms) excitatory and inhibitory responses in the CS-US 
interval.  On the other hand, short-latency responses to the CS remained relatively stable and 
the incidence of responses to the US actually increased.  The increased responses to the US 
are surprising since the IO is presumed to be a major source for the US signal.  It is likely 
that after IO inactivation with NBQX, information about the US reached the cerebellum 
through trigemino-cerebellar mossy fiber projections that are known to convey 
somatosensory information from facial areas (Woolston et al., 1981; Kassel et al., 1984; 
Ikeda and Matsushita, 1992).  This finding raises the possibility of functionally significant, 
extra-olivary US inputs to eyeblink-related IN neurons that may need to be incorporated in 
the models of eyeblink conditioning.   
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In summary, we propose that the NBQX-induced abolition of CRs was most likely 
caused by the stimulus-independent suppression of IN’s tonic rate and of its neuronal 
responses in the CS-US interval.  This conclusion contradicts Medina et al. (2002), who 
reported stimulation-dependent CR extinction during continuous injections of NBQX in the 
IO.  We could not replicate this result in spite of using the same drug concentration and a 
very similar experimental setup.  On the contrary, smaller amounts of NBQX in a larger 
group of rabbits invariably abolished CRs in a stimulation-independent fashion.  In one of 
our animals, a much smaller amount of NBQX (eight-times smaller concentration) also 
yielded CR abolition.  Two aspects of Medina et al.’s study could have contributed to this 
difference.  First of all, their study had a complex design with animals being subjected to 
infusions of picrotoxin and vehicle and to repeated extinction and CR re-acquisition sessions 
prior to their NBQX tests.  Although unlikely, it can not be excluded that these procedures 
altered the physiology of underlying circuits in a manner making them resistant to NBQX 
effects on cerebellar tonic activity.  Another possibility is that repeated injections in Medina 
et al.’s study induced the formation of glial scarring that progressively degraded the effective 
drug diffusion, yielding more delayed effects in their waiting test.  This is a common 
problem in studies that involve repeated injections at the same site.  Anticipating this effect, 
we added an additional five minutes to the waiting period test in the present study.  However, 
independent of the resolution of this conflict, our data demonstrate that NBQX injected in the 
IO abolishes CRs not because of unlearning, but by rendering cerebellar circuits 
dysfunctional.   
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3.5.2 Implications for future studies   
Although this study supports the tonic dysfunction hypothesis and challenges certain 
tenets of the cerebellar learning hypothesis, it should be emphasized that these hypotheses are 
not mutually exclusive.  The IO possibly could provide the intermediate cerebellum with the 
“teaching” US input as postulated in the cerebellar learning hypothesis while at the same 
time regulating tonic activity in the cerebellum.  This possible dual role of the IO has 
important consequences for developing experimental strategies in addressing IO participation 
in eyeblink conditioning.  New methods will have to be developed to block IO responses to 
the US without significantly affecting its spontaneous firing rate.  The important contribution 
of this study is its demonstration that blocking AMPA/kainate receptors in the IO does not 
achieve this desirable effect.  An equally important implication is that the use of 
electrophysiological recordings performed simultaneously with pharmacological 
manipulations and behavioral assessment of CRs essential for deciphering the mechanism 
responsible for changes observed following cerebellar manipulations. 
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CHAPTER 4. ULTIMATE TEST OF IO FUNCTION: BLOKING IO 
INPUTS WHILE MAINTANING ITS TONIC ACTIVITY  
4.1 Abstract 
The inferior olive is a major component of the eyeblink conditioning neural network.  
According to the cerebellar learning hypothesis, the IO functions in supplying the cerebellum 
with a “teaching” unconditioned stimulus input required for the acquisition of conditioned 
responses, and predicts that blocking this input should lead to the extinction of CRs.   
Testing this hypothesis requires blocking sensory inputs to the IO without affecting 
its tonic discharge.  Since blocking sensory inputs to the IO with glutamate antagonists 
reduces its firing rate, new approaches have to be developed to counter-balance these tonic 
drug effects.  In the present study we examined two drug candidates, harmaline and gabazine, 
for their potential to elevate the IO’s spontaneous activity.   
We found that systemic administration of harmaline abolished CRs and induced body 
tremor.  Surprisingly, intra-olivary harmaline administration had no effect on CRs, indicating 
that the systemic harmaline effect was not mediated through the inferior olive.  In contrast to 
harmaline, the GABA-A receptor antagonist gabazine injected in the IO increased tonic 
eyelid closure, shortened CR onset latency and increased neuronal activity in the IN.  These 
observations indicate that gabazine increased IO firing rate and that it could be potentially 
used to offset tonic effects of glutamate drugs on IO activity.  To assess whether gabazine 
indeed has this property, we injected the IO of trained rabbits first with the glutamate 
antagonist γ-glutamylglycine (DGG) and then with gabazine.  We found that gabazine 
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recovered CRs abolished with DGG.  Electrophysiological recordings revealed that 
behavioral recovery of CRs was paralleled by the recovery of neuronal activity in the IN.  
These findings suggest that the level of IO neuronal excitability is critical for CR 
performance and that maintaining excitability at near normal levels may be more important 
for the maintenance of CRs than are the US signals they carry to the cerebellum.    
4.2 Introduction 
The inferior olive is an important part of eyeblink conditioning circuits.  Inactivating 
or lesioning the IO blocks the expression and acquisition of CRs in the rabbit, but the 
mechanisms of this phenomenon are not known.  The cerebellar learning hypothesis suggests 
that inactivating the IO deprives the cerebellum of the teaching US signal and this translates 
into a gradual CR abolition interpreted as behavioral extinction.  Our previous results 
revealed that blocking IO activity abolishes CRs by producing a tonic dysfunction of 
cerebellar circuits (Zbarska et al., 2007).  Based on these data we concluded that the IO plays 
a tonic regulatory role in the neuronal circuit involved in classical conditioning.  This 
conclusion, however, did not disprove the cerebellar hypothesis.  This is because the tonic 
consequences of IO manipulation may have obscured the IO’s participation in learning.  As 
we indicated in our literature review, an ultimate test of the cerebellar learning hypothesis 
would require blocking sensory inputs to the IO without affecting its spontaneous tonic 
activity.   
Somatosensory information from the face reaches the IO through trigeminal inputs, 
which are known to be glutamatergic (van Ham and Yeo, 1992; Lang, 2001).  We have 
confirmed Lang’s (2001) finding that blocking glutamate has adverse side-effects in the form 
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of suppressed IO tonic activity (Zbarska et al., 2007).  Clearly, blocking sensory inputs to the 
IO to test their role in learning requires carefully calibrated methods for blocking only these 
inputs without also causing major shifts in IO intrinsic activity.  To accomplish this, we have 
been developing a new multi-injection protocol in which injections of a glutamate antagonist 
are followed by injections of another drug that would restore tonic activity in the IO.   
We tested two potential drug candidates - harmaline and gabazine – for restoring 
tonic activity.  Harmaline is an alkaloid whose systemic administration is known to produce 
synchronized rhythmic activation of IO neurons and to induce a strong body tremor (Lamarre 
and Weiss, 1973; Llinas and Volkind, 1973; Headley et al., 1976).  Also, systemic 
administration of harmaline abolishes CR expression in the rabbit, and it has been speculated 
that this effect is mediated by the IO (Turker and Miles, 1984; Harvey and Romano, 1993).  
De Montigny and Lamarre (1973) recorded from the IO during systemic harmaline 
injections, which revealed synchronized rhythmic activation in the caudal half of the medial 
dorsal accessory IO.  Local application of harmaline into the IO of decerebrated cats 
produced similar results, characterized by sustained rhythmic activity in the caudal halves of 
the inferior olive.  These authors confirmed that harmaline most likely acts directly on the 
inferior olive to produce body tremor (De Montigny and Lamarre, 1975).  Because of 
possible species-specific differences in the effects of harmaline (Miwa et al., 2006), we first 
compared effects of systemic and intraolivary injections on CR expression.  We found that 
harmaline is not suitable for restoring tonic activity because its effects on CRs are not 
mediated by the IO.  
In a second group of experiments we tested the GABA-A receptor antagonist 
gabazine, which activates the IO by blocking its inhibition (Ueno et al., 1997).  It is known 
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that the IO receives GABA-ergic projections from deep cerebellar nuclei (Fredette and 
Mugnaini, 1991; Ruigrok and Voogd, 1995; Svensson et al., 2005) and the local application 
of the GABA-A receptor antagonist picrotoxin increases tonic activity in the IO (Lang, 
2002).  Our exploratory experiments revealed that the intraolivary injection of gabazine does 
not affect CR incidence, but it does shorten CR latency and increases the baseline activity of 
IN cells. These preliminary results show that because gabazine increases neuronal activity in 
the IO, it thus has the potential for restoring tonic activity suppressed by glutamate 
antagonists.  
To assess this issue, we injected the IO in trained rabbits first with DGG and then 
with gabazine.  The results of this dual micro-injection experiment indicate that gabazine 
accelerates the recovery of CRs abolished by DGG.   These behavioral results were 
supported by pilot electrophysiological recordings showing that the recovery of DGG-
suppressed neuronal activity in the IN could also be accelerated by gabazine injections.   
4.3 Materials and Methods. 
4.3.1 Subjects 
To explore the effect on CRs of intracranial injections of harmaline, gabazine and 
their combination with DGG, we implanted four male, New Zealand White Rabbits (Harlan, 
Indianapolis, Indiana), weighing 2.5–3.0 kg (3–4 months old at the beginning of 
experiments) with injection cannulae in the IO.  To record the effect of IO injections on 
neuronal activity in the IN, one of these rabbits was also equipped with a microelectrode 
assembly in the IN for electrophysiological recording of unitary activity.  Rabbits were 
housed individually on a 12/12 hr light/dark cycle and provided with food and water ad 
libitum.  All experiments were performed in accordance with the National Institutes of 
Health’s “Principles of Laboratory Animal Care” (publication No. 86-23, revised 1985), the 
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American Physiological Society’s “Guiding Principles in the Care and Use of Animals,” and 
the protocol approved by Iowa State University’s Committee on Animal Care. 
4.3.2 Surgery 
After exposing the skull, three stainless steel anchor screws and a 28-gauge injection 
guide tube were implanted.  For targeting anterior parts of the right IO, the following 
stereotaxic coordinates were used: AP = x - (0.69x + 4.5) mm anterior to lambda (x is 
horizontal distance between bregma and lambda in mm), ML = 1.0 mm lateral to lambda, and 
DV = 22.4 mm ventral to lambda.  The patency of the injection guide tube was protected 
between experiments by a 33-gauge stainless steel stylet.  
One rabbit was implanted with a microelectrode array/micromanipulator assembly 
targeting the left IN as in (Aksenov et al., 2004).  The manipulator contained three bundles of 
microwire electrodes totaling 14 electrodes (stainless steel, 18 µm diameter, Formvar 
insulation).  The microwires were connected to a 15-pin connector embedded in dental 
acrylic.  The stereotaxic coordinates for the IN implant were: AP = x - (0.69x + 4.8) mm 
anterior to lambda (x is distance between bregma and lambda in mm), ML = 5.0 mm lateral 
to lambda, and DV = 14 mm ventral to lambda.  The guide tube, manipulator, connector, 
anchor screws, and a small Delrin block designed to accommodate an air-puff delivery 
nozzle and an eyeblink sensor were secured in place with dental acrylic.  Following surgery, 
the manipulator and injection guide tube were protected with removable Delrin caps.  All 
animals were treated with antibiotics during a 5-day post-surgical recovery period.   
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4.3.3 Training procedures 
One week post-surgery, all rabbits were first adapted to a restraint box in a sound-
attenuated experiment chamber for 3 days, 30 min per day.  Head movements were not 
restricted either during adaptation or during experiments.  Box-adapted animals were 
conditioned in the standard delay classical conditioning paradigm until they reached 90% of 
conditioned responses (CRs) for at least two consecutive days.  The conditioned stimulus 
(CS) was a binaural 450-ms, 80-dB SPL, 1-kHz tone, superimposed on a 70-dB white noise.  
As the unconditioned stimulus (US), a 100-ms, 50-psi (at the source) air puff was applied to 
the left eye.  The inter-stimulus interval was 350 ms.  The inter-trial interval varied pseudo-
randomly from 15 to 25 s.  Rabbits had one conditioning session of 100 paired trials per day 
until they reached 90% of CRs for two consecutive days.   
4.3.4 Injection procedures 
Before each injection experiment a 33-gauge stainless steel needle was inserted in the 
intracranial guide tube.  The injection needle was connected to a 10-µl Hamilton syringe 
using transparent Tygon tubing.  The pressure microinjections were performed manually at a 
rate of 0.5 µl/min.  The injected volume was monitored by observing the movement of a 
small air bubble relative to gradation marks on the transparent tubing.  During injection 
sessions, 40 trials of paired stimuli were applied prior to the injection to assure that needle 
insertion had no effect on CR performance.  Injections were not administered if rabbits had 
less than 85% CRs during the pre-injection baseline period.  NBQX (Sigma-Aldrich) was 
dissolved in artificial cerebrospinal fluid (aCSF, Medina et al., 2002) and its pH was adjusted 
to 7.4±0.1. 
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Functional mapping.  Since previous studies have shown that AMPA receptor 
antagonists decrease neuronal activity in the IO (Lang, 2002) and abolish eyeblink CRs 
(Zbarska et al., 2007) we used 1.0-µl injections of the AMPA/kainate and NMDA receptor 
antagonist, DGG (Tocris Bioscience, 100 nmol in 1µl), for functional mapping.  During the 
mapping stage, the first exploratory DGG injection was performed at the depth of the guide 
tube tip.  Mapping sessions consisted of 40 pre-injection trials and 80 post-injection trials, 
which were administered immediately following the initial DGG injection.  If no effect on 
CR incidence was observed, the depth of injection was adjusted, progressing 0.5 mm deeper 
the next day.  This daily increase of injection depth was repeated until DGG completely 
abolished CRs, or until the needle reached the base of the skull.   
Intracranial injections of harmaline and gabazine.  After an effective injection site 
was established, the separate effects of 1.0 µl of harmaline (15 g/L) and 1.0 µl of gabazine 
(0.75g/L) in the IO on CR expression were tested.  Sessions at this stage consisted of 40 pre-
injection trials and 80 post-injection trials, which were administered without delay 
immediately following the injection.  All drugs were dissolved in aCSF (Medina et al., 2002) 
and their pH was adjusted to 7.4"0.1.  Only one drug was injected on any given experiment 
day.  During vehicle control experiments, 1.0 µl of aCSF was administered into the IO using 
the same technique as in drug experiments.   
Injections during combination experiments.  After successful gabazine-alone effects 
had been established, a combination experiment was conducted.  These combination 
experiments tested whether CRs abolished by DGG can be restored by increasing IO tonic 
activity.  To block glutamate input to the IO, 1.0 µl of DGG (20 g/L) was injected just as 
during functional mapping.  Once DGG abolished CRs for at least 20 consecutive trials, the 
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experiment was paused momentarily to replace the injection needle for DGG with the 
injection needle for gabazine.  As soon as paired stimulation was resumed, 1.0 µl of gabazine 
(0.75 mg/ml) was injected to the same site at the rate of 0.5 µl/min every 40 trials without 
pausing stimulation until a change in behavior was observed, or for an additional 120 trials if 
no effects were evident.  Vehicle control experiments utilized aCSF instead of gabazine.  
Systemic administration of harmaline.  Previous studies reported that systemic 
administration of the alkaloid harmaline suppressed CR expression and produced body 
tremor (Llinas and Volkind, 1973;Turker and Miles, 1984).  To verify these findings in our 
preparation, the same four animals examined in the intracranial injection experiments were 
also tested following the systemic administration of harmaline.  In these experiments, 3.0 ml 
of harmaline (15 g/L) were subcutaneously administered after 40 pre-injection trials.  In 
vehicle control experiments, 3.0 ml of saline were administered subcutaneously.  
4.3.5 Data recording and analysis 
During experimental sessions the eyeblinks were recorded using a wide field-of-view 
infrared sensor (Ryan et al., 2006).  The sensor’s signal was amplified, digitized at 1 kHz 
with 12-bit resolution, and displayed and stored on a custom data acquisition system.  Data 
were acquired for 1400 ms in each trial, starting 250 ms before the CS onset.  Eyeblink 
responses beginning between 80 ms after CS onset and up to the US onset were considered 
CRs when they exceeded the mean of the signal in the 250-ms baseline period by more than 
five standard deviations (approximately 0.1 mm).  Spontaneous responses were defined as 
trials in which the difference between the maximum and minimum values in the baseline 
period exceeded 0.5 mm.  Any blink exceeding the CR threshold within 80 ms after CS onset 
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was recognized as an alpha response.  Trials containing spontaneous blinks or rare alpha 
responses were stored but were not included in further data analyses.  Measurements of 
eyeblink responses were used for calculations of CR incidence per block of 10 trials in each 
session.   
In addition to the visualization of eyeblink traces on the computer monitor, two video 
cameras were installed in the experiment chamber to monitor general animal behavior during 
experiments.  One camera provided a front view of the rabbit’s head and the other one, 
configured for infrared viewing, was positioned on the side of the trained eye.  This setup 
proved to be invaluable for monitoring rabbit behavior continuously.  
To monitor movements of the rabbit’s head during harmaline-induced tremor, an 
accelerometer was attached to the head stage.  Recordings from the accelerometer were 
displayed and stored in 1400-ms epochs corresponding to individual trials.  
In the rabbit implanted with microelectrodes, multiple single-unit signals were fed 
through a custom miniature 14-channel FET-based preamplifier to a multi-channel 
differential amplifier system (Grass-Telefactor model 12 Neurodata System).  The amplified 
and band pass-filtered (300 Hz-3 kHz) signal was digitized (25 kHz/channel) using a custom 
data acquisition system, and was displayed and stored in 1400-ms epochs corresponding to 
individual trials.  Unit discrimination was performed offline using threshold detection 
followed by a cluster analysis of scatter plots of time and amplitude distances between the 
peak and valley of individual action potential waveforms.  The discriminated data were 
processed using custom software in addition to a commercial data analysis package 
(NeuroExplorer, Nex Technologies).  Cross-correlation analysis was performed for each unit 
to eliminate multiple inclusions of the same unit recorded on different wires within a bundle.  
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Raster and peri-event histograms were constructed for each unit.  For cells recorded during 
gabazine-alone experiments, separate histograms were constructed for 40 pre-injection trials 
and all post-injection trials.   For cells recorded during combination experiments, separate 
histograms were constructed for 40 pre-injection trials, for 40 trials of complete DGG-
induced CR abolition and for 40 trials of complete gabazine-induced CR recovery.  All group 
data are reported as mean ± standard error of the mean.  
4.3.6 Histology 
After all experiments were completed, rabbits were deeply anesthetized with a 
mixture of ketamine (100 mg/kg), xylazine (12 mg/kg), and acepromazine (3 mg/kg).  The 
injection site was marked by injecting 1 µl of tissue-marking dye.  Anesthetized animals 
were transcardially perfused with 1 L of phosphate-buffered saline followed by 1 L of 
fixative (10% buffered formalin) and 1 L 10% potassium ferrocyanide in 10% formalin.  The 
potassium ferrocyanide was applied only to the IN-recording rabbit, where the location of 
electrodes was marked by passing 10 µA anodal DC current through each wire for 20 s.  
Brains were removed and placed in a solution of 30% sucrose and 10% formalin.  After one 
week, brains were sectioned coronally at 50 µm on a freezing microtome.  Sections were 
mounted onto gelatin-coated slides, dried, and stained with Luxol blue and neutral red, 
except for the IN recording rabbit, whose IN sections were stained with ferrocyanide 
hydrochloride and neutral red.  Locations of injection sites were determined using bright field 
microscopy and transferred to a standardized set of coronal sections of the rabbit medulla.  
Locations of electrode marks were transferred to a standardized set of coronal sections of the 
rabbit cerebellar nuclear region. 
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4.4 Results 
4.4.1 Location of injection sites and general observations 
Four rabbits were implanted with an injection cannula in the IO.  One of them also 
had recording electrodes implanted in the IN for electrophysiological recording.  The 
histological reconstruction of IO injection sites revealed that they were located in the rostral 
portion of the inferior olivary complex, close to the rostral part of the dorsal accessory 
inferior olive (Fig.1).   
All rabbits reached the 2-day 90% CR criterion in 8 to 15 training sessions.  Once 
effective injection sites were established through functional mapping using DGG, intracranial 
effects of harmaline and gabazine on CR expression were tested in separate experiments.  
Unexpectedly, microinjections of harmaline in the IO did not affect CR expression and had 
no visible behavioral side effects.  On the other hand, injections of gabazine at identical 
injection sites shortened CR latency (Fig. 2B), produced tonic eyelid closure (Fig. 2A) and 
induced head rotation to the right and a postural asymmetry characterized by limb extension 
on the left side of the body once released from the restraint box.   
Since injections of harmaline in the IO had no effect on CRs, its effectiveness was 
tested systemically by injecting it subcutaneously in the same subjects.  In agreement with 
previous studies, subcutaneous injections of harmaline suppressed CR performance (Fig. 3) 
and produced 8-11 Hz head/neck tremor as documented by the accelerometer measurements.  
This tremor, however, did not propagate to the eyelid effector system.  
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Fig. 1.  Location of injection sites in the IO in the rabbits implanted with an injection 
cannula only (●, n=3) and with an injection cannula and microelectrode assembly (  ).  The 
identified sites in individual animals were transferred to a set of standardized coronal 
sections of the rabbit medulla, arranged in rostral-to-caudal order (A-H).  All injection sites 
were found within or close to the rostral part of the inferior olivary complex.  Injections of 
DGG at all marked sites abolished CR expression.  The anterior-posterior distance of each 
section from the most rostral pole of the IO in mm is labeled on the lower right side of 
individual sections.  IOD - dorsal accessory inferior olive; IOM - medial inferior olive; IOPr 
- principal inferior olive; IOA - subnucleus A of the medial inferior olive; IOB - subnucleus 
B of the medial inferior olive; IOK - cap of Kooy of the medial inferior olive; Sp5N - spinal 
trigeminal nucleus; sp5 - spinal trigeminal tract; Pr - prepositus hypoglossal nucleus; 7N - 
facial nucleus; icp - inferior cerebellar peduncle; MVe - medial vestibular nucleus; SolN - 
solitary nucleus; AmbC - ambiguous nucleus; 12n - hypoglossal nerve; 10N - dorsal motor 
nucleus of the vagus; DCN – dorsal cochlear nucleus. 
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Fig. 2.  An example from one subject of the effects of IO injections of gabazine and 
vehicle (aCSF) on eyelid position and CR latency.  A: The eyelid aperture before and after 
gabazine and vehicle injections in the IO.  Gabazine produced tonic eyelid closure while 
aCSF did not affect eyelid position.  B: The latency of CRs was shortened after gabazine 
injections in the IO. C: Microinjection of vehicle had no effect on CR latency. 
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4.4.2 Effect of harmaline on CR expression 
Effect of intracranial harmaline injections.  Injecting 1.0 µl of harmaline in the IO 
did not affect CR expression (Figs. 3B, 4).  At the group level, CR incidence after injecting 
harmaline into the IO (90.9±4.8%) was indistinguishable from the vehicle control 
(90.5±6.7%).  The effectiveness of each rabbit’s injection site had been verified in prior 
experiments whereby inactivating the IO with DGG suppressed CRs when compared with the 
pre-injection performance (Figs. 3A, 4).  To examine whether the lack of harmaline effects 
could be related to degradation of the injection site, in the following session all rabbits were 
injected with DGG again (Figs. 3C, 4).  In all rabbits the injection site was still effective 
since DGG reduced CR incidence from 92.5±7.5% during the last pre-injection 10-trial block 
to 7.5±4.8% during the fourth post-injection 10-trials block.  Vehicle control injections at the 
same injection site did not have any effect on CR expression (Figs. 3D, 4).     
Effect of systemic harmaline injections.  The absence of an expected harmaline 
effect could implicate the quality of the drug.  To verify its potency, we conducted a systemic 
injection bioassay in the same set of animals.  In agreement with previous reports (Turker 
and Miles, 1986), subcutaneous injection of 3.0 ml harmaline (15 mg/kg) gradually abolished 
CR expression (Fig 5A).  This effect was usually incomplete with infrequent CRs still 
randomly occurring during the post-injection period (Fig. 5A).  At the group level, systemic 
administration of harmaline decreased CR incidence from 96.1±0.9% pre-injection to 
12.9±4.1% in the fifth post-injection block of trials (Fig. 4).  Subcutaneous injections of the 
vehicle control had no effect on CR performance (Fig. 4, 5B).   
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Fig. 3.  Four separate experiments from the same animal on the behavioral effects of 
intracranial injections of harmaline and vehicle (aCSF) at the IO site where DGG abolished 
CRs.  A, C: Eyeblinks from an experiment testing the effectiveness of the injection site by 
microinjecting 1.0 µl of DGG.  These tests were performed before and after the harmaline 
experiment. DGG gradually abolished CRs within 5 minutes of post-injection training, 
verifying an effective injection site.  B: Microinjecting 1.0 µl harmaline (15 mg/ml) did not 
suppress CR performance.  D:  An intracranial injection of the vehicle control (aCSF) did not 
affect CR performance.  
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Fig. 4.  Group effects of subcutaneous and intracranial injections of harmaline, two 
DGG injections and vehicle on CR incidence (±SE).  Intracranial injections of harmaline and 
aCSF had no effect on CR incidence. On the other hand, both DGG and systemic harmaline 
microinjections produced dramatic CR deficits.   
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Fig. 5.  Individual examples of behavioral effects of subcutaneously injecting 
harmaline and vehicle (saline) in the same subject.  A: After the subcutaneous injection of 
harmaline (15 mg/kg), eyeblink CRs were gradually abolished within 10 minutes of post-
injection training.  B: The subcutaneous injection of saline did not suppress CR performance.   
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4.4.3 Changes in CR performance and IN neuronal activity after injecting 
gabazine into the IO 
Since intracranial injections of harmaline did not produce expected effects on CR 
performance, we ran pilot experiments to test a second drug – gabazine – for its potential to 
elevate tonic activity in the IO.  At the IO injection site where DGG had completely 
abolished CRs (Fig.  6B), 1.0 µl of gabazine (0.75 g/L) did not affect CR incidence (Fig. 6A), 
but it did shorten CR latency from 184.2±9.0 ms in pre-injection trials to 109.3±10.1 ms in 
post-injection trials (Fig. 2B, 6A).   
Similar behavioral effects of gabazine were observed on another rabbit that had been 
implanted with an injection cannula in the IO and a microelectrode assembly in the IN (Fig. 
7A, B).  During that representative experiment, dysinhibiting the IO with gabazine increased 
the baseline firing rate of an IN neuron (Fig. 7 B, C).  This coincided with the shortening of 
CR latency (Fig.7 B, bold markers).  In the unit shown in Fig. 7, baseline activity more than 
doubled from 6.2±1.0 Hz during pre-injection trials to 14.4±0.4 Hz during 160 post-injection 
trials.  Gabazine also altered the neuronal response to the CS and US (compare Figs. 7 D and 
E).  These data are consistent with the notion of gabazine increasing IO tonic activity, and 
they suggest that this drug could potentially be used to restore its spontaneous firing rate in 
experiments blocking glutamatergic inputs to the IO.  
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Fig.6. Stack plots of all eyeblinks recorded in three separate experiments in the same 
animal showing effects of gabazine, DGG and vehicle (aCSF) on CR performance.  A: 
Eyeblinks in an experiment where 1.0 µl of gabazine injected in the IO increased the 
amplitude and shortened the latency of CRs.   B: Eyeblinks in an experiment where injecting 
1.0 µl of DGG in the same place quickly abolished CRs.  C: Eyeblinks in the control 
experiment in which 1.0 µl of vehicle (aCSF) did not affect CRs. 
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Fig. 7.  An example of the parallel effects of gabazine on CR performance and IN cell 
activity.  This experiment consisted of 200 trials with the injection administered after 40 
trials.  A: Stack plot of all eyeblinks before and after gabazine was injected into the IO 
revealing a shortened CR latency.  B: Raster plot of action potentials of a single IN unit 
during the same experiment.  The experiment starts at the top with each row representing one 
trial, and each dot marking the occurrence of an action potential.  Coinciding with the 
shortening of CR latency (the CR onset is labeled with a bold dot in each row), the firing rate 
of this cell’s activity increased as evidenced by the increased density of action potential 
markers.  C: Bar plot of the same cell showing that baseline spike frequency nearly doubled 
after gabazine was injected into the IO. D: A peri-stimulus histogram of the same IN unit 
constructed from 40 pre-injection trials reveals an excitatory response during the CS-US 
interval followed by post-US inhibition.  E: Peri-stimulus histogram of the same cell 
constructed from the first 40 post-injection trials, showing an increased baseline firing rate.  
Bin width for histograms in D and E is 20 ms. CS, onset of conditioned stimulus; US, onset 
of unconditioned stimulus. 
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4.4.4. Effects of sequential injections of DGG and gabazine into the IO on 
CR expression and on neuronal activity in the IN 
After inferring that gabazine can increase baseline neuronal activity in the IO (see 
section 3.4.3), we tested whether this drug could be used to counterbalance the tonic effects 
of glutamate antagonism.  In this experiment (see Fig. 8 for an example), glutamate input to 
the IO was blocked by injecting 1.0 µl of DGG.  Once CRs were abolished, two 1.0-µl 
gabazine injections were administered 40 trials apart at the same injection site (Fig. 8A).  
This led to a complete recovery of CRs 20 minutes after the first gabazine injection.  The size 
and shape of these recovered CRs were comparable to pre-injection CRs (Fig. 8A).  In the 
control experiment, DGG was followed by vehicle injections administered according to the 
same schedule as for gabazine in the preceding experiment.  Vehicle injections did not 
accelerate CR recovery, which emerged spontaneously much later toward the end of the 
experiment (Fig. 8 B). 
Single-unit recordings during this experiment revealed that the DGG-induced CR 
abolition coincided with suppression of the spontaneous firing rate of IN cells (Figs. 9A, B, 
C).  While CRs were abolished and baseline activity of the illustrated unit was suppressed, a 
strong excitatory response to the US developed (Fig. 9E).  After the second injection of 
gabazine the excitatory response to the US disappeared and the CR recovery was 
accompanied by the restoration of neuronal activity (Figs. 9B, C, and F).  Toward the end of 
the session the baseline activity even exceeded its pre-injection level. (Fig. 9C, F). 
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Fig. 8.  Individual examples of the behavioral effects of sequential injections of DGG 
and gabazine compared to the control injections of DGG and vehicle (aCSF) into the IO of 
the same subject.  A: After the DGG injection into the IO, CRs were abolished within 7 
minutes of resuming post-injection training.  Twenty minutes after the first injection of 
gabazine, CRs recovered with some shortening of CR latency. Their amplitude and shape 
were comparable to pre-injection CRs. B: In the control experiment, DGG again abolished 
CRs within 7 minutes.  Injecting vehicle (aCSF) in the same manner and time frame as 
gabazine in the previous experiment resulted in CRs appearing much later with latencies 
longer and amplitudes smaller than pre-injection CRs. 
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Fig. 9.  An example of the parallel effects of sequential injections of DGG and 
gabazine on CR performance and on the activity of an IN cell.  This experiment consisted of 
240 trials with the injection of DGG administered after 40 pre-injection trials and those of 
gabazine administered at trials 80 and 120.  A: Stack plot of all eyeblinks showing CRs 
gradually being abolished after DGG and then completely restored about 15 minutes after the 
second gabazine injection.  B: Raster plot of IN cell activity during the same experiment.  
The experiment starts at the top with each row representing one trial.  Small dots mark the 
occurrence of action potentials and large dots denote the onset of eyeblinks.  Coinciding with 
the timing of the behavioral CR abolition, the firing rate of this cell’s activity was severely 
suppressed.  The recovery of neuronal activity occurred after the second gabazine injection 
and it paralleled the behavioral recovery of CRs.  C: Bar plot representing changes in 
baseline activity during the experiment. D:  Peri-stimulus histogram of the same IN unit 
constructed for 40 trials before the injection.  E: Peri-stimulus histogram of the same cell 
during 40 post-DGG injection trials when behavioral CRs were abolished and cell activity 
was suppressed.  F: Peri-stimulus histogram constructed for 40 post-gabazine trials when 
complete recovery of behavior and cell activity was observed.  Bin width for histograms in 
D, E, and F is 20 ms. CS, onset of conditioned stimulus; US, onset of unconditioned 
stimulus. 
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Fig. 9. 
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4.5 Discussion and Conclusions 
The data presented here demonstrate that blocking the inhibition to the IO by the 
GABA-A receptor antagonist gabazine shortens CR latency and increases neuronal activity 
in the IN.  The most important finding was that the recovery of DGG-suppressed CRs and IN 
neuronal activity can be significantly accelerated by intra-olivary injections of gabazine.  We 
also found that systemic effects of harmaline on CR expression are not mediated by the 
eyeblink-related parts of the IO.  
4.5.1 Effect of harmaline on CR expression   
Harmaline is an alkaloid which has been known since 1894 to produce a high 
frequency tremor in mammals (Llinas and Volkind, 1973; Headley et al., 1976).  Systemic 
administration of harmaline produces an 8-12 Hz body tremor in decerebrated cats (Lamarre 
and Mercier, 1971; Lamarre and Weiss, 1973).  Single-unit recordings after systemic 
administration of harmaline revealed Purkinje cells to be rhythmically activated at 8-12 Hz 
via climbing fiber afferents from the inferior olive (De Montigny and Lamarre, 1973; Llinas 
and Volkind, 1973).  Direct electrophysiological recordings from the IO confirmed these 
results and detected rhythmic activity only in caudal parts of the medial and dorsal accessory 
inferior olive, not in its rostral half (De Montigny and Lamarre, 1973; De Montigny and 
Lamarre, 1975).  The mechanism through which harmaline affect the IO is not known. 
Systemic harmaline disrupts acquisition of conditioned nictitating membrane 
responses in the rabbit, but it does not prevent subsequent acquisition of conditioning or 
performance of unconditioned responses (Turker and Miles, 1984; Harvey and Romano, 
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1993).  Importantly, systemic harmaline also reduces the incidence of previously acquired 
CRs (Turker and Miles, 1984).  Our data confirm the latter finding.  Approximately ten 
minutes after we injected harmaline, CRs were mostly suppressed and rabbits developed 
body/neck tremor although eyelid movements were not affected by the harmaline-induced 
tremor. 
While our experiments with systemic administration of harmaline were geared toward 
reexamining previous studies, our testing the effect of harmaline injections in the IO on CR 
expression were novel experiments.  These experiments offer surprising insights in 
understanding the mechanisms of harmaline action in the rabbit.  We found that intra-olivary 
application of excess harmaline, at sites where previous application of DGG abolished CRs, 
had no effect on CRs.  These finding extend previous reports of the rostro-caudal gradient of 
IO sensitivity to harmaline (De Montigny and Lamarre, 1973; De Montigny and Lamarre, 
1975), and it suggests that the eyeblink-related rostro-medial part of the IO is insensitive to 
harmaline.  We conclude that the systemic effects of harmaline on CR performance are most 
likely not mediated by direct effects of this drug on IO eyelid representation.   
4.5.2 Effect of gabazine on CR expression and on IN neuronal activity 
Since intra-olivary injections of harmaline most likely did not increase IO tonic 
activity, a second drug candidate, gabazine was tested.  As a GABA-A receptor antagonist 
(Ueno et al., 1997), gabazine was chosen to increase tonic activity in the IO because it is 
known that the IO receives GABA-ergic afferent projections (Fredette and Mugnaini, 1991; 
Ruigrok and Voogd, 1995; Svensson et al., 2005; Bengtsson et al., 2004).   
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We discovered that activating the IO with gabazine does not affect CR incidence but 
instead shortens CR latency and increases CR amplitude.  This finding is remarkably similar 
to the phenomenon of short-latency CRs reported in experiments blocking the inhibition 
directly in the IN (Ohyama et al., 2003; Ohyama et al., 2006).  Since our electrophysiological 
recordings revealed that blocking IO inhibition increased neuronal activity in the IN, we 
propose that a similar neuronal mechanism underlies the shortening of CR latency both after 
disinhibiting the IO and the IN.  Specifically, activating the IO with gabazine most likely 
suppresses simple spikes in Purkinje cells resulting in decreased IN inhibition.  This indirect 
activation of the IN should yield a similar behavioral outcome as the direct pharmacological 
disinhibition of the IN.  It should be noted that an IO gabazine-induced disinhibition of the 
IN is relatively mild since a complete block of  GABA-A receptors or of chloride channels in 
the IN leads to CR abolition (Aksenov et al., 2004). 
4.5.3 Effects of a combined block of glutamate and GABA-A receptors  
The purpose of these experiments was to examine changes in CR expression and in 
cerebellar nuclear activity associated with blocking glutamatergic sensory inputs to the IO 
under conditions where the tonic effects of DGG were opposed by gabazine.  The results of 
this preliminary study are highly encouraging.  We found that gabazine significantly 
accelerated the recovery of CRs abolished by the prior injection of DGG.  Interestingly, the 
recovered CRs did not subsequently extinguish (as the cerebellar learning hypothesis would 
predict) - they persisted through the end of the experiments.  The behavioral data were well 
complemented by recordings of IN activity showing that the CR recovery was paralleled by 
the recovery of the IN’s spontaneous firing rate.  These findings are inconsistent with the 
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cerebellar learning hypothesis and suggest that the IO’s US signals are most likely not 
required for CR retention.   Since the IO receives inhibitory inputs from cerebellar and extra-
cerebellar sources (Hesslow and Ivarsson, 1996; Gibson et al., 2002), it is possible that the 
main IO function could be the setting of functional tonic states of the cerebellum during 
learning. 
We would like to emphasize that the above conclusion is preliminary not only 
because of the insufficient sample size, but also because of our concerns with the dynamics 
of the gabazine-induced CR recovery.  Specifically, the recovery of neuronal activity in the 
IN and of behavioral CRs was delayed when compared to injections of gabazine-alone.  We 
can not exclude the possibility that some glutamate receptors were already active by the time 
of CR recovery.  If so, then these functioning receptors may have been sufficient in 
transmitting sensory information to the cerebellum, thus preventing CR extinction.  This 
seems unlikely because in control experiments, where the same amount of glutamate 
antagonist and vehicle were injected, CR recovery occurred much later than in DGG-
gabazine experiments.  Nevertheless, addressing this question satisfactorily will require 
direct electrophysiological measurements of IO responses to the US at all stages of the 
combined DGG/gabazine experiment.   
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CHAPTER 5.  GENERAL CONCLUSIONS 
5.1 General conclusions 
We have investigated the role of the IO in the in the expression and retention of 
classically conditioned eyeblinks in the rabbit.  The main goal of this dissertation was 
examining one of the central tenets of the cerebellar learning hypothesis – the presumed 
teaching role of the IO in maintaining cerebellar traces of memory.  In the main part of the 
dissertation we focused on determining whether inactivating the IO or blocking the 
glutamatergic sensory inputs in the IO could be used for testing the cerebellar learning 
hypothesis.  In these experiments we were the first to show that inactivating the IO or 
blocking glutamate receptors in the IO abolishes CRs not because of unlearning, but because 
these interventions produce tonic dysfunction of cerebellar circuits.  These fundamental 
findings disprove established interpretations of IO manipulation experiments and weaken the 
evidence for the cerebellar learning hypothesis.  In the second part of the dissertation, we 
initiated studies with an objective to develop a principally new pharmacological protocol that 
would block IO sensory inputs without producing cerebellar tonic dysfunction.  In these 
studies we found that the physiological effects of glutamate blockers could be potentially 
offset by the GABA-A antagonist gabazine.  This finding opens a new and very promising 
route for testing IO function. 
The specific major findings of our research have already been deliberated upon in the 
discussion section at the end of each chapter.  In summary, the experiments described in this 
dissertation clearly demonstrated that: 
 133 
 
1. Inactivating the DAO with muscimol or blocking both AMPA and NMDA 
receptors in the DAO abolishes CRs on a time course most likely determined by 
the dynamics of drug diffusion, not repeated presentations of the CS-US.   
2. Blocking glutamate neurotransmission in the DAO induces tonic dysfunction in 
cerebellar circuits as evidenced by our single-unit recordings at the cerebellar 
output in the IN.   Cerebellar dysfunction and not extinction is responsible for the 
CR suppression.  
3. Selectively blocking AMPA/kainate receptors in the DAO abolishes the 
expression of well-learned eyeblink CRs in the rabbit.  Again, the gradual 
disappearance of CRs was a time-dependent function of diffusion rather than 
post-injection training.   
4. Selectively blocking AMPA/kainate receptors in the DAO decreases tonic activity 
in the IN and alters its neuronal responses to paired stimuli.  Changes in IN 
baseline activity were not stimulus-dependent.  
5. Conclusions 1-4 collectively indicate that inactivating the IO or blocking its 
glutamatergic sensory inputs does not induce unlearning as previously thought.  
We have demonstrated that all these treatments suppress CR performance by 
producing tonic dysfunction of cerebellar circuits, and not by a US-blocked 
unlearning of conditioned responses. 
6. The CR suppression that follows systemic administration of harmaline is not 
mediated by the IO as evidenced by the absence of any harmaline effects when 
injected at sites where DGG reliably abolished CRs.  The DAO seems to be 
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harmaline-insensitive, therefore, this drug is not suitable for offsetting tonic 
effects of IO glutamate blockers.   
7. Blocking GABA-A receptors in the IO shortened CR latency, produced tonic 
eyelid closure and increased the spontaneous firing rate of IN cells.  This finding 
indicated that gabazine could be potentially used to offset the tonic effect of IO 
glutamate blockers.  
8. Sequential injections of DGG and gabazine demonstrated that the recovery of 
CRs and of IN neuronal activity can be significantly accelerated by gabazine.  In 
addition, the recovered CRs did not extinguish.  These preliminary findings 
emphasize the importance of a near normal rate of IO neuronal firing for the 
performance of CRs, and that maintaining their excitability at near normal levels 
is more important for the generation of CRs than is their modulation by olivary 
inputs. 
 
 135 
 
5.2 Recommendations for future research 
The fundamental contribution of the presented research is that it explained that IO 
inactivation-induced CR deficits are a result of a learning-independent physiological 
mechanism that interferes with tests of possible IO learning functions.  Importantly, we 
believe that we found a new technique which could neutralize the tonic interference of IO 
manipulations.  Since the combined DGG and gabazine method has extremely promising 
uses and implications, our discussion of future research will focus on issues related to its 
verification and exciting applications.   
First of all, since we have presented only exploratory electrophysiological recordings 
of IN neuronal activity in combination DGG-gabazine experiments, further tests will be 
necessary to confirm our findings in a more representative sample of animals and IN 
neurons.  Assuming the confirmation of our findings, additional tests will have to be 
conducted to confirm that no US signals are conveyed to the cerebellum during the gabazine 
induced CR recovery.  Confirming this expected result would offer a principally new and 
definitive method for examining the IO contribution not only to the retention of CRs, but also 
to learning new CRs in naïve animals.  Alternatively, if the current DGG/gabazine approach 
will prove to work only in conditions of incomplete glutamate receptor block, new types of 
drug combinations, such as NBQX and picrotoxin could be investigated for their potential to 
separate the tonic and learning functions of the IO.  
Although it was not the main subject of our investigations, our research offered one 
of the best illustrations of the IO regulating tonic activity in cerebellar circuits.  Our data 
questions the physiological significance of this process.  Does the IO set a specific level of 
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cerebellar activity during certain motor and learning tasks?  Long term recordings from the 
same set of cerebellar neurons during a variety of behavioral states and learning situations 
could offer important insights into this fundamental question. 
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